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Abstract
Background Motor Neuron Disease (MND) is a group of complex neurodegenerative 
disorders that affects primarily the motor functions. Current limitation of existing MND 
models are either their ability to replicate in vivo architecture/cell-cell interactions or to 
be of the relevant species to enable better translation of laboratory results towards the 
clinic. 
Aims In order to improve transferability of laboratory results, this project aims to 
develop an alternative in vitro bioengineered three-dimensional motor neuron disease 
model. Electrospun aligned ultrafine fibre scaffolds have previously been shown to 
encourage axon alignment and elongations with submicron fibres found to be the best. 
The application of these scaffolds would provide a good foundation in the development 
of potential in vitro human MND models.
Results NSC34 cells cultured on a range of both micro- and nanofibre scaffolds identified 
nanofibres to be best at supporting neurite differentiation and growth. Subsequent 
analyses via the use of primary murine spinal cord dissociates indicated good association 
between neurons and glia akin to natural nervous tissue. However, weak immunolabelling 
of astrocyte and oligodendrocyte markers (ALDH1L1 and MBP respectively) suggested 
that they were immature cells. Relatively consistent aligned submicron fibre scaffolds 
were found to be difficult to obtain. As a result, multivariate ANOVA was conducted on 
the recorded parameters against fibre diameter distributions to find a simpler method 
of controlling the electrospinning of submicron fibres. Using previously established 
mathematical models of electrospinning as a basis, it was possible to reduce the number 
of parameters from 11 measurable parameters to 5 composite parameters. However, it 
was also noted that it may be possible to decrease the number of parameters further. 
Conclusions Aligned nanofibre scaffolds were found to be good at controlling the 
differentiation of NSC34 and primary murine spinal cord dissociates. In addition, using a 
theoretical approach to electrospinning it is possible to simplify the control of parameters 
in the generation of aligned submicron fibre scaffolds.
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Motor Neuron Disease (MND) is a complex and incompletely understood group 
of neurodegenerative disorders affecting primarily the motor functions (muscular 
responses)1,2. At present, there are five main subgroups classified according to their site 
of onset with Amyotrophic Lateral Sclerosis (ALS) being the most predominant form; 
accounting for approximately 80% of all cases. Depending on the type of MND, patients 
are often diagnosed with presenting symptoms of muscle weakness, spasticity and 
decline in ability to carry out daily functions3.  Survival of sufferers is typically in the 
range of 3-5 years from the onset of symptoms, with respiratory failure being the most 
common cause of mortality.
The motor system of any living organism is the response branch of their nervous 
network following external stimuli; such as the instant limb retraction following heat 
sensation. Due to the need for instantaneous reactions the motor system is evolutionarily 
developed to be highly receptive of signal transductions. However, this also results in a 
higher risk of neurodegeneration brought about by either physical trauma or disease.
The nervous system of higher order species is typically divided into the central 
and the peripheral nervous systems which comprise the brain and the spinal cord (CNS), 
and the nerve fibres and the ganglia (PNS), respectively. Although the maintenance 
strategies of both the CNS and PNS are relatively similar, the PNS is typically more 
capable of repair and/or regeneration following stress. However, in patients with MND 
the innate maintenance and repair/regeneration capabilities of the nervous system are 
compromised with the motor system particularly affected. Although the underlying 
causes are not completely understood, current knowledge derived from traditional 
model systems used in biological research (such as genetic screening, in vitro, in vivo, 
ex vivo and/or epidemiological models) point towards multiple factors contributing 
to motor neuron injury. The potential factors identified that can lead to MND include 
genetic mutations4, mitochondrial dysfunction5, glutamate excitotoxicity6,7 and many 
more. However, current research has yet to provide transferability of laboratory results 
towards a positive clinical outcome. 
Peripheral nerve regeneration is a developing branch within tissue engineering 
that focuses on the development of guidance conduits which aims to bridge the nerve 
gaps generated following trauma. This is achieved by the development of materials and 
1. Introduction
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constructs that can induce and enhance the natural features of native PNS regeneration. 
Microporous sponges8 or collagen hydrogels9 are some of the materials that are being 
used to mimic natural three-dimensional structures within which neurites normally 
reside. Although these structures lack directional control, small tubular conduits10 have 
been developed to be of similar dimensions and morphologies to the extracellular 
matrices of natural nerve fibres to support the repair of nerve gaps of up to 25 mm. 
Minor improvements11,12 to the regenerative potential of tubular constructs have been 
obtained by modifications such as the incorporation of microchannels13 or the use of 
aligned microfibers14,15 wrapped within a spongy fabric16. 
A major limitation to the transferability of laboratory results towards the clinic 
is sometimes attributed to the predominant use of animal models. The inherent species 
differences of such models restricts their ability to replicate human MND pathophysiology. 
In addition, with the advances made in the generation of patient-derived functional 
human motor neurons17 there are increasingly vociferous calls for the reduced use of 
animal models. In previous years, this may have been hindered by the technologies 
available to establish structural characteristics of in vitro models akin to native neural 
tissues. However, given the progress made in peripheral nerve regeneration, there is 
potential for the development of an in vitro neural tissue model for the study of human 
MND.
1.1. Motor Neuron Disease
Motor neuron disease (MND) is a group of neurodegenerative disorders characterized by 
the selective loss of motor neurons with minimal deficits towards any other physiological 
functions1,2,3. The principle form of MND is amyotrophic lateral sclerosis (ALS), accounting 
for approximately 80% of all cases. Alternative forms of MND are identified by their site 
of onset or the affected subsets of motor neurons. An overview of what is currently 
known about MND is given below.
Candy Ho MPhil 2014
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1.1.1. Motor Neurons
Classic features of MND are specific degeneration of motor neurons, which are one of 
the largest cells found within the human body. Motor neurons collectively form the bulk 
of the motor system and are responsible for relaying processed signals from the CNS 
allowing the brain to control movement by activation of skeletal muscle. Structurally, a 
single motor neuron is composed of dendrites, a soma, an axon and an axon terminus18 
(fig 1.1). The soma (or the cell body) is the principal site for protein syntheses in motor 
neurons and it is also where neuronal functions are predominantly regulated. They 
chiefly reside within the motor cortex, the motor nuclei of the brainstem and the ventral 
horns of the spinal cord along with the dendrites; whose function is to inflate the somatic 
membrane surface area for signal reception and processing. The axon on the other hand 
is responsible for signal filtering and the transmission of action potentials from the 
soma towards muscle targets19. There, axonal termini branch into structures known as 
end-plates which are dispersed throughout muscle fibres making synaptic contact with 
muscle fibres at the neuromuscular junction (NMJ). 
The structure of motor neurons, like most other neurons, is maintained 
by a framework of actin, microtubules and neurofilaments. During development, 
actin reorganisation at growth-cones following environmental cues and inter-neurite 
(a generic term identifying neuronal processes) competition results in neuronal 
polarity (differentiation of neurites into dendrites and axon)20.  The mature neuronal 
microarchitecture of microtubules and neurofilaments acts as the exchange framework 
for proteins, vesicles and mitochondria between and within the different neuronal 
compartments for normal motor neuron function21. In addition, actin filaments 
Figure 1.1: A Motor Neuron as can be found in the Nervous system
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are involved in homeostatic regulation of motor neurons as well as their dynamic 
reorganisation of neuronal structure in response of stress22,23. 
In motor neurons an action potential is typically initiated following the activation 
of post-synaptic a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-kainate 
glutamate receptors24 and/or the N-methyl-D-aspartate (NMDA) receptors25 distributed 
about the dendrites or soma18. AMPA receptors of motor neurons predominantly lack 
the glutamate receptor-2 (GluR2) subunit which significantly increases the rapid influx 
of Ca2+ ions into the motor neuron soma following AMPA receptor activation. This influx 
of ions leads to a change in local membrane potential26 which facilitates the opening of 
the voltage-dependent ion channels to enhance the exchange of Na+, K+ and Cl- ions. 
When the degree of depolarisation reaches a threshold an ionic current is driven across 
the soma and down the axon towards the axonal terminus27; thus forming the action 
potential. When the ionic current reach the nerve terminus it stimulates the exocytosis 
of the neurotransmitter acetyl choline into the synaptic cleft of specialised synapses 
known as neuromuscular junctions (NMJ). The transmission is complete when sufficient 
receptors in the post-synaptic muscle membrane have been activated to induce muscle 
contraction28.
Motor neurons are classified into either the visceral or somatic subclasses 
depending on their function. Visceral motor neurons either directly innervate branchial 
muscles (which support the face and neck muscles in land vertebrates) or indirectly to 
cardiac and smooth muscles (e.g. for the involuntary control of blood circulation and the 
gastrointestinal tract). However, it is the somatic motor neurons that degenerate in MND 
patients. These neurons principally control skeletal movements and there are two main 
types: the upper and lower motor neurons18,29. Upper motor neurons are found in the 
CNS; the cell bodies are located within the motor cortex of the brain. They collectively 
direct the activation of lower motor neurons and the acquisition of new motor skills. 
The other somatic neurons, lower motor neurons, can be found within the 
brainstem and the ventral horn of the spinal cord with extension of axons into the 
peripheral nervous system. Lower motor neurons directly innervate myofibres (the 
microstructures responsible for muscle contraction) via the NMJ29. These neurons can be 
further divided into alpha (aMN) or gamma motor neurons (gMN). The aMN innervates 
the extrafusal (contracting) myofibres for slow muscle contractions normally associated 
with voluntary movements. The gMN, on the other hand, innervates the intrafusal 
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(sensing) fibres within muscle spindles that are responsible for rapid involuntary stretch 
reflexes and muscle tone.  
1.1.2. Neuroglia (otherwise known as Glia)
Neuroglia (or simply glia) are a group of cells found within the nervous system that support 
and regulate neural functions. During embryogenesis they appear after the generation 
of neurons following the closing of the neural tube in higher vertebrates. Their specific 
roles include electrical insulation for action potentials, protection against pathogens 
and toxins, regulation of homeostasis and of free neurotransmitters plus many more30. 
Astrocytes, oligodendrocytes and Schwann cells are the primary glia directly associated 
with the survival and functions of motor neurons. 
Astrocytes are the most abundant glia found within the CNS and their most well-
known role is in the regulation of CNS homeostasis31 in support of neuronal survival32. 
In addition, they have been found to be involved in the maturation of neurofilaments33, 
stimulation of synaptic formation34 and in the regulation of the excitatory amino acid 
glutamate7. The full extent of astrocytic involvement in motor neuron survival and 
therefore MND will be discussed later. 
Schwann cells and oligodendrocytes are the myelinating, or insulating, cells 
in the PNS and CNS respectively. Although derived from two different lineages35 the 
respective functions of Schwann cells36 and oligodendrocytes37 are relatively similar. 
Apart from providing electrical insulation the process of myelination increases the level 
of phosphorylation of the dynamic neurofilaments36. This serves three principle roles: 
1) to stabilise the neuronal architecture; 2) to increase the calibre of neurites; and 3) 
to aggregate ion channels thus driving the formation of nodes of Ranvier (features of 
mature axons). A stable neuronal architecture facilitates high efficiency and systematic 
intracellular molecular transportation21. A high calibre neurite increases its cross-
sectional area which improves molecular transport and signal transmission38. Along with 
the formation of the nodes of Ranvier, these features of myelination collectively improve 
the conduction velocity of action potentials along neurites. 
Another important function of myelinating glia is in neuroregeneration39,40. 
Between Schwann cells and oligodendrocytes, the former in peripheral nerve regeneration 
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is the better known. Assuming that CNS regeneration follows a similar pattern, neural 
regeneration following injury is initiated by the demyelination and degeneration of the 
distal ends of neurites, furthest away from the soma. This process releases a gradient of 
factors (chemotactic or chemical guidance) that guides the recruitment of macrophages 
or microglia to engulf and remove debris to leave behind an empty neural tract (for 
thigmotactic, or physical, guidance for nerve regeneration). At the same time, dormant 
glial progenitors are activated and guided towards the site of injury following similar 
chemotactic and thigmotactic cues. Whilst migrating, these glial progenitors secrete 
neurotrophic factors and extracellular matrix proteins that stimulate the formation of 
growth cones of regenerating neurites41-43. In healthy tissues this will result in the re-
establishment of the neural network.  
1.1.3. Clinical Features of Motor Neuron Disease
Motor neuron disease (MND) is an umbrella term for a group of neurodegenerative 
disorders affecting primarily motor neurons. Categorised according to the site of onset 
there are four main clinical subtypes: 1) primary lateral sclerosis; 2) progressive bulbar 
palsy; 3) progressive muscular atrophy and 4) amyotrophic lateral sclerosis (ALS).
Primary lateral sclerosis (PLS) is characterised by early upper motor neuron 
degeneration localised in the bilateral corticobulbar tracts (motor neuron clusters 
supplying the face, tongue, pharynx and larynx) and corticospinal tracts (that supply the 
body and limbs). Degeneration of upper motor neurons typically presents with muscle 
weakness associated with spasticity (muscle stiffness), hypertonia (increased muscle 
tone) and hyperreflexia (hyperactive reflexes). 
Progressive bulbar palsy (PBP) describes MND caused by the degeneration of 
the branchial, visceral and lower motor neuron; localised within the cranial nerves, which 
control facial and neck muscle movements. Progressive muscular atrophy (PMA) on the 
other hand is characterised by degeneration of lower motor neurons in the spinal cord 
that supply the muscles in the rest of the human body. Degeneration of lower motor 
neurons is typically characterised by muscle wasting (atrophy), weakness and flaccidity. 
Muscle fasciculation (twitching) may also be observed.
Amyotrophic lateral sclerosis (ALS) is the most common form of MND. Sufferers 
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of ALS commonly show signs of degeneration of both upper and lower motor neurons. 
For an ALS classification the patients should exhibit early symptoms suggestive of 
a-motor neuron degeneration in the anterior (or ventral) horn of the spinal cord and 
in the motor cortex.  Individuals presenting with the other clinical subtypes of MND will 
frequently show signs of ALS in the later stages due to the spread of neurodegeneration.
The aetiology of MND has yet to be completely understood. However, results 
from existing research are pointing towards a combination of various risk factors rather 
than a single cause that can eventually lead to MND. The predominant forms of MND 
are sporadic (non-familial) in nature while ~5% of cases are attributed to familial forms 
which, though heterogeneous, and better understood. An overview of the current 
understanding of the pathology and aetiology of MND is provided below.
1.1.4. Pathophysiology of Motor Neuron Disease
MND patients are often identified by an electromyographic assessment (a test of 
electrical activity as an indication of muscle health) showing features of denervation 
with fasciculation and enlargement of motor units1. Biopsies of wasted muscles from 
MND patients would present histological features of denervation with grouped atrophy 
of muscle fibres and thinning of the motor nerve roots.  However, sensory nerve fibres 
and units would appear to be unaffected.
Major pathological features of post-mortem CNS tissues of MND patients are 
often shrinkage, sclerosis and pallor of the corticospinal tracts within the brain stem 
and the descending motor pathways of the spinal cord44,45. Atrophy of the precentral 
gyrus (part of the motor cortex) is also commonly seen in post-mortem MND brains46. In 
addition, significant increases in end-plate branching can be observed.
Histological examination of MND tissue samples frequently display a reduction 
of more than 50% of all spinal motor neurons. In addition, diffuse astrogliosis (excessive 
multiplication of astrocytes) are often observed within the grey matter of the spinal cord, 
motor cortex and the underlying subcortical white matter47. Surviving motor neurons in 
MND have been found to exhibit cytoplasmic protein aggregates which can be positively 
immunolabelled for ubiquitin48,49.  These ubiquitinated inclusions are often positive for 
TAR DNA-binding protein 43 kDa (TDP-43)49. Alternatively, some histological samples 
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of MND cases display the presence of Lewy-like bodies which are fused with swollen 
mitochondria5,50. Morphological changes reflecting atrophy of the degenerating axons 
may also be observed21,51. 
1.1.5. Molecular Mechanisms Contributing to Motor Neuron Degeneration
Inter- and intracellular molecular interactions govern the micro and macro processes 
that enable species survival. In MND, hereditary genetic mutations found in familial ALS 
(fALS) are the better understood molecular contributors although they only account for 
~5-10% of all MND cases. However, MND is not a purely genetic disease and current 
understanding of its molecular pathophysiology is explored below.
1.1.5.1. Genetic Factors
Over the years, multiple hereditary genes had been identified to be associated with the 
pathophysiology of MND52,53. A recent review by Ferraiuolo et al46 highlighted eighteen, 
primarily autosomal dominant, genes linked with fALS that were classified into 8 different 
subsets according to their principle molecular functions.
The most well-known toxic gene mutation in MND is found in the copper-zinc 
(Cu-Zn) superoxide dismutase (SOD1), located on 21q22, that is associated with oxidative 
stress. Lesser known genetic contributors of fALS include genes for proteins associated 
with glutamate excitotoxicity (d-amino acid oxidase, encoded by DAO54, and localised on 
12q24), endosomal trafficking and cell signalling (Vesicle-associated membrane protein 
associated protein B, VAPB55,56, on 20q13.3; Optineurin, OPTN57,58, on 10p13; and Alsin, 
ALS259, on 2q33), RNA processing (Fused in sarcoma, FUS60,61, on 16p11.2; and TAR DNA-
binding protein, TARDBP62,63, on 1p36.2), ubiquitin/protein degradation (Ubiquilin 2, 
UBQLN264, on Xp11) and cytoskeletal regulations (Microtubule-associated protein tau, 
MAPT21, on 17q21). 
A recent discovery in MND is the hexanucleotide (GGGGCC) expansion in the 
first intronic region of the C9ORF72 (chromosome 9 open reading frame 72).  Normal 
individuals can have up to 30 repeats, but in ALS cases there are more than 30 and 
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often several thousand repeats65-67. The presence of these repeat units accounts for 
approximately 10% of all ALS cases (40-50% of fALS and approximately 7% of apparently 
sporadic disease)65. However, the precise pathogenesis has yet to be determined. 
1.1.5.2. Glutamatergic Excitotoxicity
A notable epidemic of ALS/Parkinson disease complex (ALS/PDC) found within the 
Chamorro tribe in Guam provided an early indicator to a potential aetiology of MND68. 
By secondary ingestion of b-methylaminoalanine (BMAA, of cyanobacterial origin found 
in cycads) from Guam fruit bats (Pteropus tokudae and P. Mariannus and a source of 
protein for the Chamorro tribe) an over-stimulation of the AMPA receptors, normally 
activated by pre-synaptic glutamate release, was proposed as a pathogenic mechanism6. 
Glutamate is a common amino acid that is frequently used as an excitatory 
neurotransmitter in the CNS. Post-synaptic signal transduction following glutamate 
activation is principally regulated by AMPA and NMDA receptors. In motor neurons, 
AMPA receptors are the predominant regulator of signal transduction. This is due 
primarily to the low expression levels of the GluR2 subunit of AMPA receptors in motor 
neurons which increase their permeability to Ca2+ ions69. Calcium ions are responsible for 
a vast array of downstream processes. However, excessive activation, by glutamate or 
similar molecules like BMAA, could lead to toxic levels of Ca2+ influx which is collectively 
known as glutamatergic excitotoxicity7.
Extracellular glutamate levels in the human CNS are regulated by glutamate 
transporters, or excitatory amino-acid transporters (EAATs) 1-5, via a sodium-coupled 
active uptake70. In rodents EAAT1-3 are known as glutamate aspartate transporter 
(GLAST), glutamate transporter 1 (GLT1) and excitatory amino acid carrier 1 (EAAC1) 
respectively71. EAATs exhibit distinct localisations such that only one form can exist per 
neuronal or glial cell type44. EAAT3-5 are largely expressed in neurons, whereas EAAT1-
2 are more commonly associated with astroglia72. EAAT1 is predominantly expressed 
in developing astroglia while mature astrocytes mostly express EAAT2 (known as GLT-
1 in rodents). Selective inhibition and knock-out studies of GLAST, GLT1 and EAAC1 
have identified astroglial EAATs to be primary regulators of extracellular glutamate73. 
Using porcine astrocytes it was found that EAATs regulate glutamate levels by active 
uptake then release across the blood-brain barrier for removal74.  A body of evidence 
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has emerged that decreased expression and function of EAAT2 may contribute to the 
glutamatergic excitotoxicity found in ALS7.
1.1.5.3. Mitochondrial Dysfunction
Due to their significant size and niche motor neurons require disproportionately higher 
levels of energy provided by greater amounts of mitochondria (a common organelle of 
all mammalian cell types). However, this importance also highlights the susceptibility of 
motor neurons to neurodegeneration if mitochondria were to dysfunction. 
In neurons mitochondria are mostly distributed within the soma, at nodes 
of Ranvier, presynaptic and postsynaptic terminals, active growth cones and axonal/
dendritic branches where there are high metabolic demands. Mitochondria are 
typically recruited from the soma (anterograde, or forward, transport) by the activation 
of glutamate receptors and/or elevated Ca2+ levels75 (high levels of which can induce 
apoptosis). In healthy mitochondria contact with high concentrations of Ca2+ stimulates 
the production of adenosine triphosphate (ATP, which is the principle energy source for 
cellular functions) as well as functions enabling the reduction of cytosolic Ca2+ levels. At 
the same time, these processes initiate the docking and release of mitochondria from 
transport molecules76. When docked mitochondria become exhausted or dysfunctional, 
retrograde (backward) transport molecules latch on to its membrane receptors and 
return the mitochondria back to the soma for degradation.  
A typical degradation pathway of dysfunctional mitochondria is thought to be 
via the autophagy-lysosomal system located within the soma. However, they have also 
been known to undergo fission to remove damaged compartments which can fuse with 
travelling lysosomes77. In some MND cases these mechanism behave unusually and 
swollen dysfunctional mitochondria have been observed to fuse with lysosomes forming 
Lewy-like bodies. The increased stress of the significantly enlarged Lewy-like bodies 
create expansion fractures on their membranes which releases cytochrome c into the 
cytosol leading to premature apoptosis50,78. 
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1.1.5.4. Oxidative Stress
Following post-synaptic membrane activation, elevated calcium levels stimulate oxidative 
phosphorylation of adenosine diphosphate (ADP) to form ATP; to supply energy for 
downstream responses. The synthesis of ATP accounts for up to 98% of total oxygen 
consumption79 and carbon dioxide production of all cells.  However, the remaining 2% of 
oxygen consumed in respiration is converted into reactive oxygen species (ROS, such as 
superoxide, O2-, nitric oxide, NO, and related species e.g. OH•) via the electron transport 
chain associated with the inner membranes of mitochondria80. 
ROS, including free radicals81, are a group of oxidising species that have a short 
half-life. As they are very unstable and highly reactive, elevated levels can potentially 
lead to indiscriminate attack towards the genome and proteome resulting in irreversible 
molecular insults to proteins, lipids and nucleic acids that affect cell survival82,83, known 
as oxidative stress. More recently ROS have been identified as physiological regulators 
and downstream signalling species of redox homeostasis, metabolism, immunological 
defence and tissue regeneration/repair. They are frequently produced as catalytic 
initiators or as facilitators to the removal of molecular debris during inflammation80. 
However, extensive physical insults or repetitive micro traumas, often experienced 
by football players5,84 or any other contact sports, may result in a sustained state of 
inflammation as their tissues are under constant repair; leading to a higher susceptibility 
to molecular damage, and tissue pathologies including MND85. This can often be detected 
by specific biochemical markers of oxidative stress which were found to be elevated in 
some CNS tissue biopsies and/or cerebrospinal fluid (CSF) of MND patients86,87.
In living organisms ROS levels are regulated by free radical scavenging enzymes 
which are predominantly members of the superoxide dismutase (SOD) enzyme family, 
and also involves the glutathione system (glutathione-s-transferase, reductase, oxidase). 
In humans, the principle SODs are the cytoplasmic Cu-Zn superoxide dismutase (SOD1) 
and mitochondrial manganese (Mn) superoxide dismutase (SOD2) and extracellular SOD 
(SOD3). SOD2 predominantly resides within the mitochondrial matrix to help regulate 
the disproportionately higher levels of ROS from mitochondrial activity88. Although 
mutations in SOD2 have not been found as a major contributor in fALS89, Ala-9Val 
mutations in SOD2 had been found to be a risk factor in female patients with sporadic 
ALS (sALS)90. 
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At high levels of oxidative stress mitochondrial forms of copper chaperones 
recruit and activate cytosolic SOD1 to support SOD2 functions in the mitochondrial 
intermembrane space (MIS)88. SOD1 is a protein dimer that removes ROS by catalysing the 




) via its copper-zinc centre82. 
Structural comparisons between the SOD1 protein and its common familial ALS mutants, 
which accounted for approximately 20% of fALS cases91, identified conformational 
changes of the mutant protein dimers which increased the catalytic distance between 
the Cu-Zn centres92. This resulted in decreased binding of catalytic Zn-centres which 
mediated the gain of non-specific, yet toxic, redox reactions93. However, it had also been 
shown that glycation (addition of reactive glucose species) of SOD1, rather than their 
mutations, that accelerated aging of motor neurons by inactivating SOD194. 
An additional artefact of SOD1 mutations is their role in stimulating the 
upregulation of nitric oxide synthase (NOS)95 leading to the generation of an excess of 
nitric oxide96,97. Nitric oxide is a highly membrane-permeable but relatively stable non-
toxic small molecule with principle roles as a vasorelaxant and a neurotransmitter98. 
Within the central nervous system NO is commonly released by astrocytes during periods 
of high metabolic demand to boost local nutrient supplies as well as to regulate synaptic 
signal transmissions. It is a strong competitor with SOD1 for superoxide and its toxicity is 
derived from its reaction product peroxynitrite (NO
3
-) when it is in excess of the capacity 
of SOD, either due to SOD1 mutations or dysfunctional NO regulatory pathways98,99. 
Peroxynitrite is a selective oxidative species with a strong affinity for thiol 
groups. It had been implicated in the deamination of guanosine and cytosine which 
affect healthy processing of the genome100 by increasing the rate of mutagenesisis. Its 
toxicity had also been attributed to its role as an intermediate in lipid peroxidation101 
which affects membrane integrity. 
Within the proteome peroxynitrite principally attacks tyrosine residues due to 
its thiol content; thus forming its nitration product 3-nitrotyrosine. Tyrosine is a major 
component in structural proteins, such as neurofilaments and actin, with the thiol groups 
contributing towards their stability. As a result, the presence of 3-nitrotyrosine affects 
monomer-packing which results in fragile cytoskeletal architecture99. As 3-nitrotyrosine 
is highly stable with a lack of native degradation pathway, it is commonly used as a 
biomarker of oxidative stress98,102. 
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Glutathione peroxidase is a downstream regulator of ROS. Its primary role is in 
the degradation of hydrogen peroxide into water via its reaction with the small molecule 
glutathione. It is also involved in the reduction of lipid hydroperoxides to their respective 
alcohols. Glutathione peroxidase and its selenoprotein cousins had been implicated as 
potential regulators of peroxynitrite103. However, the inactivation of its selenocysteine 
catalytic centre on contact with peroxynitrite limits their possible contributions towards 
the regulation of oxidative stress104. 
In other oxidative stress models, an established G93A-SOD1 mutant motor 
neuron cell line (a neuroblastoma x spinal cord hybrid, NSC-34) identified a decrease 
in the levels of the antioxidant response elements (ARE) and nicotinamide adenine 
dinucleotide phosphate (NADPH)5,105, which are both regulators of ROS106. However, the 
cause and consequence of such changes have yet to be fully understood. 
1.1.5.5. Protein Aggregation/Malformation
Protein aggregation is a common feature in neurodegenerative disorders. In MND, 
aggregates are often compact or skein-like ubiquitinated inclusions. Ubiquitin is a 
relatively common small molecule protein indicator for proteosomal degradation107. 
In certain cases, X-linked mutations of Ubiquilin 2 (UBQLN2), a ubiquitin-like protein, 
has been implicated in interfering with the protein degradation pathways leading to 
aggregation of misfolded proteins64. Another observation was the high proportion of TDP-
43-associated cytoplasmic aggregates in MND. TDP-43 is usually found predominantly 
within the nucleus in healthy motor neurons although the cause for its re-distribution in 
some cases of MND has yet to be determined22,78. 
Pathophysiological studies of mutant SOD1 models of ALS in mice and some 
human MND post-mortem tissues have exhibited aggregates of the usually cytoplasmic 
SOD1 within the intermembrane space of mitochondria. Adhesion of the aggregates 
to mitochondrial membrane were also observed and this phenomenon appeared to 
increase with age52,108. In combination, these abnormalities affect portions of the electron 
transport chain eventually culminating in dysfunctional mitochondria which are likely to 
contribute to motor neuron injury. 
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1.1.5.6. Cytoskeletal Abnormalities
Actin filaments play a critical role throughout neuronal development and survival22. The 
production and dynamic reorganisation of actin facilitates environmental sensing109 for 
growth cone motility in neurite elongation110, synapse formation and function111, vesicle112 
and mitochondrial76 trafficking, as well as structural support for the development of the 
microtubule and neurofilament networks. In addition, a review by Janmey in 1994113 
implicated cytoplasmic Ca2+ levels and downstream phosphoinositide signalling, 





in actin filamentous gel-sol (solid-liquid) transitions that are necessary for cytoskeletal 
reorganisation, although both are also known to affect neuron survival. However, actin 
filaments are also regulators of ROS and apoptosis by directing the recruitment of 
mitochondria76 and lysosomes, as was demonstrated in studies of yeast (Saccharomyces 
cerevisiae)75,76.
During development or regeneration, neurofilaments are the first structural 
proteins of neurons to form. As neurites grow and elongate, the myelination process 
of glia facilitates the exclusive phosphorylation of axonal neurofilaments as a means 
of stabilising axon structure. Mature neurofilaments are predominantly composed of 
the three main subunits: heavy (NF-H, 200-220kDa in an SDS-PAGE); medium (NF-M, 
145-160 kDa) and light (NF-L, 68-70 kDa). Although current studies have yet to confirm 
the contribution of mutant neurofilaments to MND, deletion mutants of NFH had been 
found to be a potential contributor116. In addition, some pathological studies of MND 
models have exhibited phosphorylated somal neurofilaments117 while selective loss of 
neurofilaments were found in cases of SOD1 mutant models118 (potentially caused by the 
presence of 3-nitrotyrosine, see section 1.1.5.4).
Microtubules are major structural proteins in neurons formed by cross-linkages 
of a- and b-tubulin on actin networks. They are highly dynamic during development to 
enable remodelling. As neurites mature into axons microtubules are stabilised by the 
binding of the small molecular weight protein tau (encoded by MAPT) which enables 
cargo transportation between neuronal compartments21. Genetic mutations in MAPT119 
had been implicated in the loss of tau-mediated stabilisation of microtubules which 
resulted in the strangulation of axons; potentially contributing to the development of 
ALS, dementia and Parkinsonism52. 
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Supported by the microtubule network, cytoplasmic dynein and microtubule-
dependent kinesin aid retrograde and anterograde transport, respectively. In mutant 
SOD1 ALS models decreased expression of KIF3B (a kinesin-like protein)91 had been 
observed which appeared to disrupt axonal transport. However, the disruptions were 
found to be cargo-specific as only anterograde mitochondrial transport appeared to be 
affected76,120. Interestingly, additional mutations in the dynein motor protein alleviated 
the interruptions resulting in extended motor neuron survival121.  
1.1.5.7. Abnormal RNA Processing
Disruptions to RNA processing are common features in MND. The earliest known forms 
of such are genetic defects to the survival motor neuron 1 gene (SMN1), or its loss, that 
contributed towards the pathogenesis of spinal muscular atrophy (SMA, an autosomal 
recessive form of motor neuron degeneration usually of childhood onset). SMN proteins 
along with partner molecules to form small nuclear ribonucleoproteins (snRNPs) that 
are involved in pre-mRNA splicing122. Although the exact pathophysiological features 
of SMN1 mutations or loss of the SMN protein in SMA are not yet fully understood 
abnormal SMN1-2 copy numbers, the latter of which is an alternative but less critical 
gene for SMN, had been implicated in some ALS cases123.
 TDP-43, as previously mentioned, is a predominantly nuclear protein that has 
a high affinity for UG/TG dinucleotide repeats in RNA, which suggests an involvement 
in RNA processing63; such as transcription, alternative splicing and the maintenance of 
RNA stability. Genetic defects in TARDBP that code for TDP-43 only accounts for 1-4% 
of all ALS. However, the redistribution of TDP-43 from nuclear localisation to within 
cytoplasmic aggregates in ~90% of all cases, including sporadic ALS, suggests an important 
involvement in the pathophysiology of ALS.
 FUS, also known as translocated in liposarcoma (TLS), is a nuclear protein 
associated with post-transcriptional RNA splicing. Genetic mutation of the FUS gene 
accounts for approximately 4% of fALS and < 1% of sALS cases61. The most common 
forms of mutations are located in the C-terminals of FUS, important for its recognition 
by transportin for nuclear uptake, which resulted in its elevated presence within the 
cytoplasm and their subsequent recruitment to stress granules in ALS124. 
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1.1.5.8. Glial Cell Dysfunction
Recent developments in the study of MND are the identification of neuron-glia 
interactions that led to selective motor neuron degeneration. Within the CNS, motor 
neurons primarily interact with astrocytes (the general regulatory glia), oligodendrocytes 
(supporter of neuronal function and survival) and indirectly with microglia (resident 
macrophages of the CNS). 
Astrocytes are the most predominant glial cell type found within the central 
nervous system. They act as environmental, metabolic and homeostatic regulators, as 
well as part of the blood-brain barrier to protect neuronal function59,125-127. However, 
when astrocytes no longer function normally they can become toxic32,127. In astrocyte-
motor neuron co-culture models, this toxicity was demonstrated by the recovery 
observed when isolated fALS and sALS post-mortem patient astrocytes128 or ALS-linked 
mutant SOD1 astrocytes29,100 was replaced with healthy astrocytes129. However, there is 
evidence to suggest that astrocytes were themselves resistant to such toxicity130. 
Under normal circumstances, reactive astrogliosis within the brain stimulates 
neural stem cell (NSC) differentiation for neuroregeneration following injury or re-
patterning131. However, within the brain stem and spinal cord, where NSCs are sparse, or 
when astrocytes differentiate atypically132, proliferation of astrocytes occupies the cavity 
where degenerating neurons once resided. This results in the formation of glial scars and 
the loss of localised innervation as can be seen in some MND cases51.
Oligodendrocytes are glia cells which promote axon development37 and CNS 
myelination133,134. Like neurons, oligodendrocytes are post-mitotic and their regeneration 
is via the differentiation of either of two types of progenitors (oligodendrocyte 
precursor cells in the subventricular zone of the brain or Sox10/Olig1-positive cells 
in the ventral spinal cord. ‘OPC’ for simplicity)35. During mild CNS axonal injury, like 
Schwann cells, oligodendrocytes cause demyelination and undergo apoptosis to signal 
for the differentiation of OPC for regeneration40. However, the mechanism or extent of 
repair has yet to be determined. In addition, there are still uncertainties as to whether 
dysfunction of oligodendrocytes has any contributing role to the pathogenesis of MND. 
Given that astrocytes are the primary regulators and supporters of oligodendrocytes 
against oxidative stress135 it raises an interesting question on how the resulting diminished 
capacity of oligodendrocytes could exacerbate MND pathophysiology. 
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Elevated levels of neuroinflammatory response are often observed in ALS136. 
This can present itself by increased microglia activity that is stimulated by the presence 
of pro-inflammatory cytokines, ROS, nitric oxide (NO) and other inflammatory mediators. 
Following activation, these microglia proceed on to a phagocytic state which initiates the 
immune response137. Similarly, during neuroregeneration following injury microglia are 
activated to mediate the removal of cellular debris39. However, in MND the sustained 
cell stress can potentially maintain a continuous inflammatory state, leading to a vicious 
cycle of neuronal injury. Although this is still a hypothetical assumption, it may account 
for the higher levels of inflammatory response observed in MND137.  
1.2. Models of Motor Neuron Disease
Motor Neuron Disease is a group of neurodegenerative disorders with multiple clinical 
phenotypes, contributing factors and pathophysiological features affecting primarily 
the motor neurons. These neurons are themselves one of the most difficult subclasses 
of mammalian cell types to study due to their inability to divide mitotically following 
specialisation. Primary motor neuron cultures are commonly derived from embryonic 
rodents and require careful culture conditions and support from neurotrophic factors to 
promote in vitro survival. 
Motor neurons are the first class of neurons to appear during embryogenesis; 
throughout the neural patterning stage as the neural plate begins to fold. They are 
produced following asymmetrical differentiation of neural stem cells (NSC)138. Their 
differentiation is dependent on neurotrophic factors secreted by target cells, which also 
provide chemotactic guidance for neurite growth. In addition, neighbouring neurons 
and glia (which have a regulatory role in homeostasis) play very important roles towards 
their maturation and survival. This reliance makes them highly sensitive to minute 
changes in their environment; thus, further increasing the level of difficulty of obtaining 
and generating long-term viable models to observe the disease progression in MND. 
Although significant progress has been made in deciphering the underlying molecular 
mechanisms with current MND models, positive laboratory results have yet to be 
successfully translated into beneficial clinical outcomes. An overview of these current 
models is reviewed below.
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1.2.1.  In Vitro Models
Simple models in the study of MND typically use in vitro monocultures of motor neurons 
derived from either healthy animals or biopsies of patients. As the simplest form of 
model, they provide isolated as well as relatively modest conditions for the study of 
the physiological and the molecular functions of motor neurons. Although the optimal 
period of isolating pure cultures of viable motor neurons are during development, their 
source is limited to the biopsies of the adult spinal cord (where the cell bodies of motor 
neurons reside). The process of extraction itself is highly dangerous as it creates lesions 
in the spinal cord, which is effectively removing localised innervation. At the same time, 
the health of the extracted motor neurons is not guaranteed. Embryonic motor neurons 
are the most able to cope with in vitro culture conditions but the ethics behind the use 
of human embryos are highly complex. As a result, most models are presently conducted 
using embryonic rodent motor neurons, as the hosts are sacrificed whilst the procedures 
were less ethically challenging. 
An alternative to the use of primary cells for in vitro model use is the motor 
neuron cell line NSC-34, which is a neuroblastoma x spinal cord hybrid. This murine cell 
line closely resembles the early stages of motor neuron development and retains many 
of the features of mature motor neurons. In addition, their ability to multiply in culture 
allows for the generation of large numbers of motor neurons for experimentation139. 
The use of NSC-34 models had been beneficial in the understanding of motor neuron-
like glutamate sensitivity140, neurotoxicity141, mitochondrial dysfunction108 and genetic 
susceptibility to MND105. However, as with all other cell lines, the results obtained, while 
useful, are limited due to the inherent abnormal phenotype of these cells.
1.2.2.  In Vitro Co-Culture Models
Co-culture systems are increasingly being employed in research as more is understood 
about the interdependent intercellular interactions. Motor neurons are some of the 
largest cells found in nature (potentially more than 1m in length in humans) and as they 
are also under a constant state of readiness (in preparation for signal transduction), they 
have high metabolic demands. In order to cope with all the stresses generated as a result 
of their normal role, surrounding glial cells provide paracrine signalling and homeostatic 
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regulation to enhance motor neuron survival in addition to providing supportive roles in 
repair/regeneration. 
Glia support motor neurons in a number of different ways. During neurite 
development and regeneration Schwann cells and oligodendrocytes deposit extracellular 
matrix proteins (such as laminin, poly-L-lysine etc.) to provide topographical cues for 
neurite differentiation and growth41,142. At the same time, they also secrete neurotrophic 
factors which support neuronal polarisation20 and survival143. As axons develop (or 
regenerate), physical contact between the membranes of axons and oligodendrocytes/
Schwann cells drives the process of myelination144,145 and the generation of nodes 
of Ranvier36; thus enabling axon maturation in preparation for signal transmission. 
Astrocytes, on the other hand, serve multiple other regulatory functions (reviewed in 
1.1.5.8, and below). As techniques in co-culture systems are gaining maturity, the role of 
astrocytes in motor neuron disease is becoming more evident32,146.
In the study of MND the rodent astrocyte-motor neuron co-culture model 
developed by Nagai et al147 is of particular importance. In their study, it was identified that 
the presence of Cu-Zn superoxide dismutase (SOD1) mutations within motor neurons in 
itself was insufficient to cause motor neuron degeneration. It was specifically the toxic 
soluble factors (generated from a Bax-dependent pathway), secreted by astrocytes with 
SOD1 mutations, which stimulated the degeneration in vitro of both primary and stem 
cell-derived motor neurons. 
In another astrocyte-motor neuron co-culture model reported by Jacquier et al59 
the dysfunction of Als2/alsin (a transmembrane protein transporter subunit associated 
with some juvenile forms of ALS, PLS and infantile-onset ascending hereditary spastic 
paralysis) was investigated. From their research it was discovered that astrocytes did 
not express alsin and were able to release a >500 Da neuroprotective (but relatively 
unstable) factor which selectively improved lower motor neuron survival.
In a less disease-specific study Nishida and Okabe33 developed neuron-
astrocyte co-culture models and ex vivo rodent brain slice models to investigate 
dendritic arborisation (formation of branches or spines) and maturation. It was found 
that the stabilisation of dendritic protrusions of neurons was dependent on the Rac-1 
signalling involved in astrocyte motility. In addition, it was found that via the ephrin/
Eph signalling pathway physical contact between astrocytic processes and primitive 
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dendritic protrusions facilitated maturation of dendritic spines as well as the formation 
of synapses at dendritic termini.
In a different in vitro model Das et al148,149 developed a serum-free co-culture of 
myocytes and embryonic motor neurons. From this study they were able to demonstrate 
that early and short-term application of neurotrophic factors was sufficient to drive the 
maturation of motor neurons, myocytes and functional neuromuscular junctions (NMJ).
However, despite the developments of these alternative in vitro models for 
the study of MND, such co-culture models are still restricted in their ability to replicate 
native intercellular interactions. One of the principal factors are their lack of structural 
similarities to natural nerves or the distinctive spatial segregation of cell types found 
in the nervous system. For such evaluations ex vivo or in vivo models had been used 
instead.
1.2.3.  Ex Vivo Tissue Models
An alternative to in vitro co-culture models is the use of ex vivo nervous tissues which 
retain the majority of native features150. The most commonly used forms of such MND 
models are post-mortem tissue samples from either laboratory animals pre-disposed to 
genetic and/or epidemiological risk factors151,152 or human MND patient autopsies with 
consent44. 
Depending on the time since death and the stage of disease progression 
nervous tissue slices could be evaluated in two ways. The classical method is by spatial 
immunohistochemical studies after formaldehyde or cryo-preservation treatments 
as used by Kersatis et al48 in the determination of ubiquitin-positive inclusions of 
frontotemporal dementia with MND. Samples prepared via this method have a very long 
shelf-life, but they are limited in their ability to inform on metabolic processes. 
A different method is the explantation of live nervous tissue slices which are 
commonly used in the study of glutamatergic excitotoxicity153-155, synaptic responses156, 
dendritic arborisation33 and astrocyte toxicity59,73,152. Carefully prepared explanted spinal 
cord slices can survive in culture for months, which made them a common choice as a 
therapeutic model150,157. 
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Unfortunately, as live ex vivo models are still derived from post-mortem sources 
they are often not healthy enough to study the molecular mechanisms of disease 
progression in MND. In addition, the stress imposed upon extraction may have been 
sufficient to influence the observed behaviours of the tissues themselves as well as limit 
any observable pathogenesis following the induction of further neuronal stress factors.
1.2.4.  In Vivo Models
For the study of more complex behaviours of MND, animal in vivo models are primarily 
used. The intact nervous system as well as the presence of peripheral biological interactions 
in in vivo models allow researchers to study the disease progression, phenotypical 
expression and the pathophysiology of MND. Likewise, they are used as the final stage 
models to identify potential adverse events before therapeutic treatments could be put 
forward towards clinical trials. However, animal models are fundamentally different to 
humans biologically. Similarly, they are also unable to present generic systemic data 
as they have limited genetic and metabolic diversity158; due to potential inbreeding in 
sterile artificial habitats. In addition, there have yet to be successful translation of in vivo 
therapeutic treatments for MND towards positive clinical outcomes. 
To generate in vivo models of MND, experimental animals are genetically 
modified or pre-exposed to potential risk factors to express similar traits or symptoms. 
The simplest in vivo models are of invertebrates due to their relatively short gestation 
period and lifespan. Similarly, their relatively better known cell differentiation patterns 
during embryogenesis permitted the tracking of the lifecycle of target neurons. However, 
they are only able to provide information on fundamental biomolecular interactions of 
human MND due to the lower phylogeny of these species. At present, the most common 
invertebrates used are nematodes (i.e. roundworm, Caenorhabditis elegans)159 and 
arthropods (i.e. fruit fly, Drosophila melanogaster160). 
Caenorhabditis elegans is frequently used in mechanistic studies as these 
invertebrates have gene homologs of approximately 42 % of human genetic disorders. 
In terms of MND they have been used to study SMN1/2 (gene ortholog, smn-1), SOD1 
(sod-1), MAPT (ptl-1)159 and TARDBP (tdp-1)161. In addition, their translucent bodies have 
allowed morphological studies of neurons as they undergo neurodegeneration once 
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selected cells have been transfected to express green fluorescent proteins (GFP) or a 
related marker protein. 
As they share almost 74% of their genome with human, Drosophila melanogaster 
have previously been employed in genetic screening for potential mutations of human 
neurodegenerative disorders160. One such study in Drosophila identified novel VAPB 
mutations56 which resulted in increased aggregate deposition, changes in endoplasmic 
reticulum function and pathological up-regulation of protein chaperones, which were 
found to be similar to some cases of MND.
Going up the evolutionary tree and as ‘next step’ platforms for MND research 
following in vitro models rodent (e.g. mouse, Mus musculus50; and rat, Rattus norvegicus), 
fish (e.g. zebrafish, Danio rerio162) and non-human primate (e.g. cynomolgus monkeys, 
Macaca fascicularis163) models have been developed. 
Mice are the most predominant animal models used in MND research164 as they 
require the smallest of housing facilities and are fairly docile due to an extensive history of 
laboratory breeding. The experience and knowledge that came with decades of research 
using mice also allowed for better experimental flexibility as the biological correlations 
between mice and human systems are well known. The most common strains of mice 
used in MND research are transgenic Cu-Zn superoxide dismutase mutants with mice 
exhibiting SOD1-G93A mutations showing the greatest degree of similarity to human 
ALS-like pathophysiology50. Studies conducted using these strains of mice have informed 
researchers on downstream motor neuron degeneration pathways165, irregularities in 
mitochondrial function5 and axonal transport120 amongst many others as contributing 
towards MND. However, despite significant advances, neuroprotective therapies 
developed in mouse models have yet to be successfully translated into treatment 
benefits for MND patients in the clinic.
Zebrafish, on the other hand, are less commonly employed in the study of MND 
as they require a much bigger facility due to the need for water tanks and specialised 
filtration systems. However, the translucent bodies of zebrafish enable the use of 
fluorescent proteins in macroscopic studies. Along with the vast quantities of potential 
offspring as well as their amazing regenerative properties, zebrafish are a popular choice 
among researchers. In the study of MND SOD1-G93R mutant zebrafish line had been 
developed and was shown to exhibit developmental NMJ changes as well as late stage 
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motor neuron loss typical of MND162. However, normal metabolic functions of zebrafish 
occur at 28oC as opposed to 37oC in the mammalian systems, which along with their 
relatively distant genetic composition make them less suitable as human MND models.
Non-human primates are the closest animal models that have recently been 
employed to study human MND. Cynomolgus monkeys (Macaca fascicularis) with 
mutant versions of TDP-43, developed as an alternative model of MND, were observed to 
display pathophysiology synonymous with the human form of the disease. This included 
a-motor neuron degeneration as well as TDP-43 re-distribution into the cytoplasm163. 
However, the much greater interactive capability of non-human primates demands 
much greater ethical clearance and there are still no guarantees of clinical transferability 
of results from research using non-human primates.
1.2.5. Stem Cell-Derived Motor Neuron Disease Models
Although still in its infancy, stem cell-derived disease models are rapidly emerging as 
alternatives to traditional in vitro and in vivo MND models166. When given the right stimuli, 
stem cells, with their pluripotency, could be induced to develop into motor neurons167. 
This is a promising method as vast quantities of human motor neurons could be derived 
from a single source. In addition, as human cells could be used it would significantly 
improve the transferability of experimental results towards a clinical outcome. At present 
there are three primary sources of stem cells: i) embryonic; ii) mesenchymal; and iii) 
somatic cells with induced pluripotency. 
Christou et al168, Jordan et al169, Erceg et al170 and Soundararajan et al171 are 
examples of research groups that focused on the use of embryonic stem cells (ESC) with 
the last group successfully generating motor neurons characterised to be typical of those 
from the medial motor column. However, there are many ethical concerns regarding the 
use of ESC, especially those of human origin. The main discontent regarding their use 
are their supply as the only legally accepted source in the UK are generous donations of 
excess embryos from IVF treatments. 
Mesenchymal stem cells (MSC) are multipotent cells derived from biopsies of 
adult patients. Unlike ESC, MSC are restricted by their source location to the range of cells 
that they could differentiate into. Although adipose-derived MSC have been successfully 
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differentiated into Schwann cells172 due to the same lineage, there are still only limited 
successes in generating motor neurons from bone marrow stem cells173.
Fibroblasts are one of the most common somatic cells found in the body as 
their primary function is as regulators of extracellular matrices. By controlled gene 
expression (or transfections of select transcription factors) they have been shown to 
convert into functioning motor neurons. At present there are two routes employed with 
varying success in generating human motor neurons, specifically those derived from ALS 
patients17. The most common and with better conversion rates are via the intermediary 
induced pluripotent stem cells (or iPSC)174,175. The other, with increasing development, is 
the direct conversion of fibroblasts into motor neurons, thereby skipping the iPSC stage 
entirely176. Although, like MSC, these somatic cells are primarily derived from patient 
biopsies, the amount of useful cells are much more significant.
 1.3. The 3Rs in Biomedical Research
While there have been extensive research towards an understanding of the 
pathophysiology of MND, limitations of current models, both in vitro and in vivo, are 
caused by their restricted transferability towards a clinical setting either due to structural 
or species relevance. In addition, due to ethical concerns, there are increasingly 
vociferous calls for the refinement, reduction and replacement (3Rs) of animal models 
within the research community. There is, therefore, a need for an alternative type of in 
vitro model where the complexity and the three-dimensional structure of human neural 
tissues could be replicated to improve current understanding of human MND. 
Neural regeneration is a field in tissue engineering where biodegradable polymer 
scaffolds are being tailored to support the repair of damaged nerves following injury177. 
As such, it specialises in the design and production of guidance conduits to mimic the 
natural structures of nervous tissues. By understanding the developments and current 
techniques employed in nerve regeneration their application could be further extended 
into potential designs for more advanced and relevant in vitro MND models.
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1.3.1. Neural Regeneration Scaffolds for PNS
Early nerve regeneration studies focused on the repair of peripheral nerves following 
injury as it is the most common form of nerve damage178. As such they are responsible 
for a significant proportion of current understanding in nerve recovery following injury. 
As long as damage did not extend into the soma within the CNS, repair is initiated 
by demyelination, then the regeneration of growth cones at the proximal end of the 
damage for neurite re-growth; as in development. Subsequent activation of Schwann 
cells facilitates the degradation and removal of distal axons away from the injury site. 
However, unlike in development, the guidance of PNS regeneration following minor 
injury (such as natural wear-and-tear) is controlled by a combination of chemotactic 
(neurotrophic factors secreted by differentiating Schwann cells) and thigmotactic cues 
(fine tubular structures known as the Bands of Büngner). Ultimately, this results in the 
reconnection of the nervous network39. However, in major nerve injury, such guidance 
mechanisms are lost resulting in permanent damage. 
Traditionally, minor gaps between peripheral nerve fibres are surgically stitched 
together by either allografting or autografting of low priority nerves for major gaps. 
Although surgical sutures connecting both ends of the nerve fibres facilitates nerve 
regeneration, if the gaps were too wide there may be restriction to muscle movements. 
In allografting, tissue rejection is a constant threat that would require permanent use 
of immunosuppressant therapy.  In autografting, on the other hand, tissue rejection is 
unlikely but it will lead to donor site morbidity16. 
Early guidance conduits in peripheral nerve regeneration, as an alternative 
to nerve grafts, are small tubes with internal diameters of up to 5 mm.  Due to a lack 
of internal structure these conduits are limited to the support of nerve regeneration 
between gaps of up to 25 mm12. 
Next generation guidance conduits incorporate the use of inner microchannels 
of less than 100 mm diameter to provide additional thigmotactic guidance13. The 
associated increase in surface area allowed for better control of Schwann cell migration 
and secretion of neurotrophic factors in a uniform direction.  However, dimensions of 
microchannels similar to that of the endoneurium (typically of no greater than 5-6 mm in 
human) are difficult to construct, as they are dependent on the manufacturing methods 
and the chemistry of materials used. In addition, the reduction in exposed membrane 
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surface area (due to the channel walls acting as physical barriers) would limit any 
potential cell-cell interactions. 
A different approach of introducing internal structures to guidance conduits 
is the use of aligned ultrafine fibres (of either micro or nanometre diameters)14,15,179. 
Rather than spatial controls as in the microchannels, the fibres control neurite growth by 
restricting the surface area available for environmental sensing. Although the processing 
parameters for the control and construction of ultrafine fibres are highly complex, the 
manufacturing costs are significantly lower. In addition, the increased exposure of 
membrane surfaces – as a result of the decreased total contact points or channel wall 
coverage – would improve intercellular interactions.
In some peripheral nerve regeneration models the introduction of Schwann cells 
into bioactive conduits180 of fibre scaffolds has been seen to improve axonal regeneration. 
Significant improvements have also been observed in the guidance of axon growth of 
explanted rat dorsal root ganglia by aligned fibre scaffolds14,181; although there have yet 
to be studies investigating their effects on motor neuron regeneration.
1.3.2. Scaffolds of CNS Regeneration
Neural regeneration in the CNS is much more complex and is only just beginning to be 
understood182. As the neural network within the brain and spinal cord are highly intricate, 
regeneration following damage are typically very slow. 
Following injury, reactive astrocytosis (or astrogliosis) signals for microglia 
activation to support the degradation and removal of localised extracellular matrix 
(ECM), disconnected neuronal components and damaged glial cells. However, due to 
the different regeneration rates of glia and neurons, astrocytes quickly proliferate and 
occupy the empty regions thus forming glial scars.  This results in localised sclerosis 
(scarring and thickening) in the region of injury which creates a hostile environment for 
regeneration of nerve processes.  To restrict such growth as well as to re-introduce pre-
damage structures sponge-like materials8 and hydrogels9 have been assessed in vitro 
that have shown promise. 
There are a number of techniques to introduce microporosity within a biomaterial 
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scaffold. The most technologically straightforward techniques involve Solvent Casting 
& Particulate Leaching (SCPL), Gas Foaming and Freeze-drying to produce sponge-like 
materials. Additionally, a versatile and accessible technique to produce a micro- or nano-
porous fibre mat is electrospinning. One of the major benefits of these scaffolds is the 
ease with which they could be batch processed and kept in storage before use. However, 
for them to function as both a barrier to astrocytosis and support for neural regeneration, 
there must be a control of pore size which can vary significantly between batches.
Additionally, hydrogels can be used as scaffolds to embed neural stem cells9 
or Schwann cells183 to enable regeneration. The cross-linking density of the hydrogel 
is an important factor in the control of cell growth as heavily cross-linked hydrogels 
generally retards neurite growth. However, unlike sponges hydrogels are physically and 
mechanically more similar to the extracellular matrix found within the CNS. 
Unfortunately, it must be noted that despite significant advances, such 
technologies are still in development and it is likely to take several years before they 
could be translated into clinical studies.
1.4. Scaffold Fabrication
A major component in the development of a three-dimensional in vitro model is the 
fabrication of the scaffolds. Aligned micro or nanofibre scaffolds are good constructs in 
the control of neurite growth14,15 to support nerve regeneration. The restrictions imposed 
by the small surface area of the ultrafine fibres limit environmental sensing during neurite 
elongation thus maximising guidance. For the same reasons, the reduced membrane 
surface coverage allows for greater cell-cell interactions, specifically those between glia 
and motor neurons. This makes them suitable structures for the development of three 
dimensional in vitro human MND models (simplified to ‘MND models’ from henceforth). 
1.4.1. Material Selection
Biocompatibility and biodegradability are two principle properties that warrant significant 
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thought in the development of biological scaffolds. The biocompatibility of a material is 
its ability to co-exist within a biological system184. Although there are still ambiguities 
in its definition, the most important properties of any biocompatible material are their 
lack of immunogenicity, toxicity, as well as tolerance of biological stresses. For a material 
to be well suited for the development of an MND model it must ideally have a similar 
mechanical property as nerve tissue. In addition, the surface chemistry185 of the material 
must also be well adapted to allow for cellular environmental sensing109 which affects 
cell adhesion, differentiation and axonal guidance of the motor neurons. 
Biodegradability, on the other hand, is a material’s ability to degrade under 
physiological conditions into non-toxic or readily resorbable by-products. Although not 
essential for the development of MND models, the incorporation of this property into 
the design process can broaden the applications of the final model. This can include 
potential therapeutic CNS / PNS tissue replacement or in the traditional application as 
scaffolds for nerve tissue regeneration following injury. 
With known biocompatibility, biopolymers are the most common of all the 
materials currently used in the generation of aligned fibre scaffolds for nerve regeneration. 
Complex biopolymers such as collagen181,186 and cellulose187 are commonly found in vivo 
as they typically form the extracellular matrices (ECM) of many mammalian organs. 
Along with silk fibroin188, of Bombyx mori (silkworms), and chitosan189, of crustaceans, 
they form the main bulk of materials used in this group. However, they are expensive to 
obtain as well as difficult to electrospin190 due to their complex molecular structures and 
their relative insolubility in solvents of reasonable volatility (explained further below). 
In addition, these biopolymers have immunogenic potential if they are not thoroughly 
cleaned before culture with cells, as they are often xenogeneic in origin. 
Simple organic polymers are gaining increasing popularity in nerve regeneration 
research due to their much cheaper relative costs, non-biological origin and the fact that 
they are relatively easy to electrospin191 (explored below). Two of the most commonly 
used simple organic polymers are poly-L-lactic acid (PLLA)15,192 and polycaprolactone 
(PCL)179,181, primarily because of their known biocompatibility and biodegradability. 
Of the two polymers, PLLA is the earlier polymer to be employed in the 
development of aligned ultrafine fibre scaffolds for nerve regeneration. The free acid 
groups on the polymer chains allow for better hydrophilicity (adsorption of water), 
which in turn improves cell adhesion. A previous study using electrospun aligned PLLA 
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micro and nanofibre scaffolds as nerve guides found that, apart from neurite guidance, 
it also improved the differentiation of neural stem cells (or NSC). In addition, evidence 
also suggested a preference of NSCs for nanofibre scaffolds, with better differentiation 
rates, as well as more pronounced maximum neurite length15. However, the mechanical 
properties of PLLA (tensile modulus = 3-4 GPa193) are not well matched to simulate ECM 
of in vivo nerve tissues (tensile modulus ~ 0.1 MPa194), which limited their use for nerve 
regeneration.




- ) is another very popular 
simple organic polymer which is closer mechanically (tensile modulus = 7-22 MPa195) 
to the ECM of in vivo nerves. In addition, the relatively inaccessible ester groups on 
PCL lead to slower biodegradation rates, as well as improving scaffold flexibility196. A 
previous study using aligned PCL microfibers demonstrated controlled regeneration of 
dorsal root ganglion neurons, with parallel-aligned neurites adhering to and extending 
along the fibre surfaces for over 2mm per ganglion body.  Co-localised Schwann cells 
were also observed to form intimate intercellular contact along the length of the 
neurite processes14, thus making aligned PCL microfibers an attractive material in the 
development of experimental in vitro MND models.  
1.4.2. Scaffold Production - Electrospinning
Electrospinning is a relatively cheap and versatile method for the production of micro and 
nanofibre scaffolds. By careful preparation of materials and optimisation of processing 
parameters, fibrous scaffolds of selected fibre diameter and morphology could be 
obtained. This section provides a summary of theoretical principles that are needed to 
be taken into consideration when embarking on the selective production of aligned fibre 
scaffolds towards a submicron level using electrospinning. 
In electrospinning there are three principal types of apparatus classified 
according to the type of jets produced: 1) upward jets; 2) downward jets and 3) horizontal 
jets. At present, a significant proportion of studies report on the use of the downward jet 
systems, whereby fluid flow is accompanied by the force of gravity. However, with this 
set-up, if the electrostatic instabilities are not well balanced with the viscoelastic ones, 
the resulting scaffolds are prone to droplet contamination. Upward jet systems, on the 
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other hand, are less prone to such issues, but they require more energy to generate as 
well as to drive the jets towards the collector against gravity. With horizontal jet systems 
(diagrammatically represented in fig 1.2) gravity only has a partial influence which limits 
droplet contamination on the product fabrics whilst at the same time reduces the energy 
required to drive the electrostatic jets.
Neurite alignment is one of the target features in the development of MND 
models. In electrospinning the alignment of the fibres is primarily controlled by having 
the electrostatic instabilities overpowering the viscoelastic ones197. One method is to 
employ the use of a rapidly rotating collector with angular velocity (va) at or exceeding jet 
velocity, in place of static plates. This improves fibre alignments by limiting the available 
orientations of the deposited fibres. Another is the addition of a charged focusing (metal) 
ring located midway along the dispensing needle to enhance the induced perpendicular 
magnetic field. This would further align electrospun ultrafine fibres, as demonstrated in 
fig 1.3 and further explored below. 
1.4.3. Principles of Electrospinning
At the start of electrospinning a polymer solution is supplied into a conducting 
capillary (i.e. syringe needle) where it is subjected to an electric field, determined by a 
Fig 1.2: Diagramatic representation of a horizontal electrospinnig rig used to produce aligned microfibers. PE = Electrical Power 
input; P
F
 = Power input from fluid motion; PD = Power used to overcome air resistance or drag; z = height of polymer dispensing 
from table surface; va = angular velocity; l = length of needle; x = distance from needle tip to rotating drum; and r = radius of 
rotating drum
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combination of applied voltage (V)198, flow rate (Q)199, capillary surface area to volume 
ratio200. Depending on the overall electrical permittivity (the dielectric property) and 
conductivity of the different components of the polymer solution, charge is accumulated 
unevenly, causing electrostatic instabilities. This unstable accumulation of charge reaches 
equilibrium by distributing themselves across the only exposed surface located at the 
needle tip where remodelling of the polymer solution (or fluid) is possible. At regions 
of high surface charge densities the surface stretches and shifts into conical structures 
known as Taylor cones, where the surface charges are more evenly distributed. When 
this build-up of charge exceeds the surface tension keeping the solution as a single unit, 
droplets or beads are generated201. However, if the viscosity of the polymer solution 
(fluid) is sufficiently high the correspondingly higher surface tension would preferentially 
stretch the beads to form electrostatic jets which would eventually solidify into the 
electrospun polymer fibres. However, if the polymer solution is subjected to a sufficiently 
high electric field, those that surpass its Rayleigh limit (the total amount of charge that a 
material can hold), the solution surface bursts thus forming an electrospray. 
The Rayleigh limit of a polymer solution is governed by its dielectric constant 
that can be controlled via the use of carefully selected solvents that takes into account 
both their overall polarity and volatility. Polar and/or ionic solvents (or polymers) 
are generally better at capturing charge202, which helps to increase the Rayleigh limit 
allowing for more stable formation of electrostatic jets. However, their comparatively 
slower solvent evaporation rate means that thicker fibres are generated, as it tends to 
Fig 1.3: The effects of electric field, as represented by the magnetic field, on the path of the electrostatic polymer jets. With the 
addition of the focusing ring, it further extends the critical straight jet length, marked by X, At this point the viscoelastic instabilities 
overcome the electrostatic instabilities leading to a ‘whipping’ effect where the jet can travel in any direction within the highlighted 
red region.
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decrease the polymer relaxation time (considered below). On the other hand, lower to 
non-polar solvents are less conductive, but the decrease in the Rayleigh limit as a result 
allows for the formation of smaller Taylor cones leading to the production of much finer 
electrostatic jets. This also means they are more likely to result in an electrospray. In 
effect, depending on the diameter of fibres that is desired, the best solvent system is the 
one that balances the formation of the Taylor cone with the stability of the electrostatic 
jet.
The propulsion of the electrostatic jet towards the collector is via the action of 
the electric field induced along the x-axes as well as the perpendicular electromagnetic 
field along the yz-plane. The gradient of the electric field drives the acceleration and 
stretching of the electrostatic jet towards the collector. In contrast, the electromagnetic 
field governs the critical straight jet length203, which affects the relative alignments of 
the electrospun polymer fibres. These two parameters are collectively influenced by the 
potential difference (equivalent to V) between the charged capillary and the grounded 
collector as well as the distance of the gap between them (x)204. Although the electric 
field along the distance x decreases, it is the steepness of the gradient that affects 
the point, denoted X in fig 1.3, where viscoelastic instabilities dominate, leading to 
the whipping effect205. By controlling the position of point X along the x-axis, either by 
manipulating the electric or electromagnetic field, alignment of the electrospun fibres 
can be achieved.
1.4.4. Effects of Viscoelastic Instabilities
The electrospinning of a material is in effect the stretching of the fluidic state so that on 
collection they can be deposited as ultrafine fibres. The stretching and re-modelling of 
the electrostatic jet are governed by the viscoelastic instabilities. These are principally 
derived from the dynamic inter- and intramolecular interactions between the component 
molecules of the fluid; denoted as the molecular relaxation time (l), elasticity (G) and 
viscosity (m). 
The molecular relaxation time describes the time it can take for a single molecule 
to collapse into its most stable form. With polymers, it is a good indicator of the degree 
of entanglement of the polymer strands which can influence on their elasticity and 
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viscosity. Typically, the more tangled the polymer chains are the longer their relaxation 
times. With greater molecular relaxation time, decreases in the elasticity and viscosity 
of the polymer are commonly observed. However, such correlations are only general in 
principal as a poor equilibrium of these properties can lead to a phenomenon known as 
“beads-on-a-string”206, which affects fibre consistencies.
The viscosity, also described as the fluid thickness, is a property that only exists 
when a material is in a liquid-fluid state as it describes material flow. It also describes how 
easily a material could be remodelled to minimise external stresses. In electrospinning, 
the fluidic state of the electrospun polymer could either be obtained as melts207 or as a 
solution. As melts the polymers are in a relatively pure form which exhibits strong Van 
der Waals forces by the accumulation of many areas of weak intermolecular bonding of 
similar or identical molecules. Such interactions could be further enhanced by increasing 
the length of the polymer chains as it encourages the formation of additional molecular 
bonds by chain entanglement.  Collectively, these properties contribute towards an 
increase in viscosity which make them much harder to electrospin; resulting in thicker 
fibres200. 
The viscosity of a polymer solution is determined by the concentration of 
the polymer and the composition of the solvent systems208-210. High concentrations of 
polymers increase both the molecular relaxation time and the viscosity. This increase can 
be alleviated by carefully designing solvent systems to limit the molecular interactions by 
increased solvation to decrease viscosity. However, the influence of the solvent system 
on the overall electrostatic instabilities (mentioned previously) must also be taken into 
account. 
The elasticity of a material describes how readily it can return to their original 
shape when the external stresses are removed. It often correlates with the surface 
tension and is the principle cause of the whipping effect observed when the electrostatic 
instabilities are no longer dominant, i.e. at point X in fig 1.3. This can often be manipulated 
by adjustment of the molecular weight, Mr or chain length, of a polymer, which affects 
the degree of chain entanglement. However, if the polymer chains are not sufficiently 
relaxed such that they have a high molecular relaxation time, this could determine the 
difference between the generation of electrostatic jets or an electrospray.
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1.4.5. Environmental Influence on Electrospinning
Electrospinning is the combination of a dynamic equilibrium between electrostatic 
and viscoelastic instabilities. It is described that the electrostatic instability governs jet 
formation, acceleration, as well as relative alignments, while the viscoelastic instability 
controls jet morphology. However, the deposition of the scaffold fibres is governed by 
environmental parameters that affect the rate of solidification and subsequent time-
dependent changes.  
The rate of solidification is affected primarily by standard environmental 
parameters such as the atmospheric air pressure, temperature (T) and relative humidity 
(f)211 although via different routes for polymer melts or solutions. However, under 
laboratory conditions atmospheric air pressure is relatively constant and is mostly 
ignored. 
An increase in relative humidity typically decreases the rate of solidification. 
In melts, this occurs by the increased surface tension due to a lower air density, which 
limits molecular air-to-jet interactions. With polymer solutions, the increased relative 
humidity decreases the rate of the solvent evaporation because of the smaller difference 
between vapour density of the solvents on the surface of the jets and the density of the 
humid air. 
An increase in temperature on the other hand affects polymer melts and 
solutions differently. At higher temperatures, the rate of solidification decreases 
for polymer melts. However, it increases the rate of solvent evaporation for polymer 
solutions which both increases the rate of solidification as well as decreasing the rate of 
decrease in molecular relaxation time. The significance of the latter lies in the fact that 
it can result in increased occurrences of the “beads-on-a-string” effect due to increased 
polymer chain contractions.
Another less well-considered environmental factor is the electrical conductivity 
(or dielectric properties) of the surrounding air as it affect the conduction of the 
electrostatic jets, which in effect completes a circuit, as demonstrated in the schematic 
shown in fig 1.2. A higher electrical air conductivity, which commonly correlates with a 
higher relative humidity212, appears to improve the critical straight jet length which can 
better align the deposited fibres.  
Candy Ho MPhil 2014
40 41
1.5. Aims and Objectives
MND is a group of neurodegenerative disorders with complex epidemiology, 
pathophysiology and aetiology. As a majority of existing experimental MND models are 
of non-human in origin, positive laboratory results have yet to be translated into success 
stories in the clinic. Current developments in the use of human stem cells are beginning 
to generate data useful in unravelling the pathogenesis of MND17,168,213.  However, such 
models are limited in their ability to provide complex neural tissue data for MND due to 
the lack of three-dimensional structures similar to those found in vivo. Therefore, the 
major aim of this project is to:
1. Identify the ability of micro- vs nanofibres in the control of neurite growth.
Aligned electrospun microfibre14 and nanofibre15 scaffolds have been successfully 
developed in tissue engineering to support the controlled regeneration of ex vivo 
peripheral nerves214. However, increasing evidence is pointing towards the use of 
nanofibres as they had been found to enhance neuron maturation215,216 as well as 
enhancing motor neuron development217. Preliminary experiments via the use of 
a motor neuron cell line NSC-34 (neuroblastoma x spinal cord hybrid)139 will be 
conducted on both aligned micro- and nanofibres to select for the most suitable 
fibre diameter for use in the development of an in vitro human MND model.
2. Develop primary neuron-glial co-culture models on aligned fibre scaffolds.
Once the selection of micro- or nanofibres have been made, similar experiments 
would be conducted on these scaffolds with primary murine motor neuron 
cultures to determine their effects on cell survival and differentiation. As glial 
cells35 have also been implicated as contributors towards the pathophysiology of 
MND218, their effects on establishing defined in vitro MND tissue models will also 
be evaluated via the use of primary murine dissociated spinal cord cultures.
3. Develop alternative methods for the control of electrospinning of 
submicron fibre scaffolds.
One of the major factors limiting the more general adoption of aligned nanofibres 
in nerve regeneration is the technical difficulty in obtaining high quality electrospun 
submicron fibre scaffolds. This is due primarily to the intricate interdependence 
of processing parameters where minor changes could affect the morphology 
of the final scaffolds. Using theoretical models of electrospinning as a basis, an 
attempt is made to simplify/improve the control of processing parameters to 
obtain submicron fibre scaffolds.
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2.1. Materials
All solutions were made under sterile conditions where possible and stored at 4oC unless 
otherwise stated.
2.1.1. Polymer Solutions
PCL: Polycaprolactone (Mr = 80,000, Sigma 440744). DCM: Dichloromethane stabilised 
with methanol for HPLC (Fisher D/1859/17). Chloroform: 1.489g/mL stabilised for HPLC 
(Fisher C/4966/17). Polymer Solutions: 5% w.t, 8% w.t., 10% w.t. and 20% w.t. PCL was 
dissolved in 1:0, 1:1, 3:1 ratios of DCM-chloroform to make up 5 ml of polymer solutions. 
The polymer was allowed to dissolve between 3 hrs to overnight in sealed containers at 
room temperature. When not in use they were stored under 5oC in total darkness for up 
to 2 months.
2.1.2. Buffers
PBS: Phosphate Buffered Saline 1x tablet (Fisher BPE9739-1) dissolved in dH
2
O as in 
manufacturer’s specification. HBSS: Hank’s Balanced Salt Solution without Phenol 
Red (Lonza 10-527F); sterile filtered at 0.22mm. HBSS+: 50ml HBSS; 5 ml 55mM 
b-mercaptoethanol (Invitrogen 21985023); sterile filtered at 0.22mm
2.1.3. Surface Coatings
pORN: 50mg/ml Poly-dl-ornithine hydrobromide (Sigma P-8638) in 0.15M borate 
buffered saline pH 8.2. Laminin: laminin (Invitrogen 23017-015) 125 ng/ml in HBSS. PLL: 
0.1% w/v poly-l-lysine in water.
2. Materials and Methods
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2.1.4. Immunopanning
p75: 1:5000 mouse monoclonal anti-p75 NGF receptor antibody (Abcam ab8877/
ab10495) in 10mM Tris, pH 9.5; freshly prepared.
2.1.5. Media Compositions
NSC Medium: 40ml of 4.5 g/l High glucose DMEM + l-glutamine (Invitrogen 41966052); 
400µl of 10,000 units penicillin and 10mg/ml streptomycin solution in H
2
O (Sigma P4333); 
and 4ml of foetal calf serum (Invitrogen 16140071). Serum Reduced NSC Medium: 20ml 
of 4.5g/l High glucose DMEM + l-glutamine (Invitrogen 41966052); 1ml of 20x stock 
solution Ham’s F12 (Invitrogen 21700075); 19ml dH
2
O; 400ml of penicillin/streptomycin; 
400ml of foetal calf serum (Invitrogen 16140071). Primary Motor Neuron (PMN) Base 
Medium: 50ml of Neurobasal Medium (Invitrogen 21103-049) supplemented with 1% 
Glutamax-1 (GIBCO 35050); 5 ml b-mercaptoethanol 55mM (Invitrogen 21985023); 
sterile filtered at 0.22mm. PMN Supplemented Medium: 50ml of Neurobasal Medium 
(Invitrogen 21103-049) supplemented with 1% Glutamax-1 (GIBCO 35050); 1 ml 
Horse Serum (Linaris SHD3250YK); 1 ml B-27 Supplement 50x (Invitrogen 17504); 5 ml 
b-mercaptoethanol 55mM (Invitrogen 21985023); sterile filtered at 0.22mm.
2.1.6. Dissociation Solutions
TrypA: 10mg/ml Trypsin with Phenol red (Worthington TRL 3, 3707) in HBSS, colour 
adjusted to salmon by addition of NaOH. TrypI: 500mg Trypsin inhibitor with Phenol 
red (Sigma T6522) in 49ml HBSS and 1ml of 1M HEPES (pH 7.4, 20mM end conc.) 
Depolarisation solution: 30mM KCl and 0.8% NaCl in dH
2
O. 
2.1.7. Sample Prepartions, Immunolabels and Fluorescent Stains
Formalin: 27 ml 37% formaldehyde (Sigma F1635); 73 ml dH2O. Triton: 0.5% Triton 
X-100 (Sigma T8787) in PBS. BSA: Bovine Serum Albumin (Sigma A4503). DAPI: 5 mg/
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ml 4’,6-diamidino-2-phenylindole (DNA-conjugated, labs = 364nm, lem = 454nm, Sigma 
D9542) in PBS. P
n
: primary antibodies in 1% BSA in PBS, dilution as in table 2.1,. S
n
: 
secondary antibodies in 1% BSA in PBS diluted as in table 2.2.
2.2. Electrospinning
Electrospinning of micro-/nanofibres was conducted using the rig set as illustrated in fig 
2.1. To start, 1 ml syringes (4.776 mm internal diameter) were fully loaded with 5 – 20 
wt% polycaprolactone (Mr = 80,000) in chloroform-dichloromethane (0:1, 1:1 and 1:3) 
solutions then capped with a blunt 24G syringe needle (0.55 x 40mm, outer diameter x 
length). Excess air was then expunged before the syringes were set onto the dispenser 
and connected to the circuit from its base. A focusing ring (60 mm inner diameter x 10 
mm length) was also connected to the circuit in parallel to and positioned mid-way along 
the needle. The polymer solutions were dispensed at constant flow rates (0.3, 1 or 2 ml/
hr) via a WPI Aladdin-220 syringe pump. The electric field was induced via the Genvolt 
73030 power pack at 8-20 kV, 50Hz. Positioned 5, 10, 15 or 20 cm away from the tip of 
the needle, a conducting drum (d = 65 mm, l = 150 mm, and motorized to 2000 r.p.m. 
by an IKA Labortechnik RW20.n stirring motor) was covered with aluminium foil and 
connected to the neutral end of the circuit for the collection of the deposited fibres. A 
ID Fluorophor l
abs





Fluorescein 494 nm 521 nm Rabbit IgG Goat Vector Lab FI-1000 1.5 mg/ml
S
2
Fluorescein 494 nm 521 nm Rat IgG Rat Vector Lab FI-4000 1.5 mg/ml
S
3
Texas Red 595 nm 615 nm Mouse IgG Horse Vector Lab TI-9000 1.5 mg/ml
S
4
Texas Red 595 nm 615 nm Rat IgG Goat Vector Lab TI-9400 1.5 mg/ml
Table 2.2: Fluorescent Secondary antibodies. labs = peak absorption wavelength; lem = peak emission wavelength; conc. = 
concentration
ID Antibody Identifies Source Distributor Dist. ID Conc. Used
P
1
Anti-b III Tubulin Neuron Mouse Promega G7121 0.5 mg/ml
P
2
Anti-Islet 1 Motor Neuron Rabbit Abcam ab20670 0.5 mg/ml
P
3
Anti-S100b Glia Rabbit Dako Z0311 4.0 mg/ml
P
4
Anti-ALDH1L1 Astrocyte Mouse Abcam ab56777 0.5 mg/ml
P
5
Anti-MBP Oligodendrocyte Rat Abcam ab7349 1:1000
P6 Anti-GFAP Astrocyte Rabbit Abcam ab7260 0.5 mg/ml
Table 2.1: Primary Antibodies for the identification of the cell types listed. Dist. = distributor; conc. = concentrations
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CRD-130-630Y temperature and humidity probe was used to monitor the environmental 
conditions of the electrospinning region between charged capillary and collector every 
15 mins. The effective temperature and relative humidity quoted for each sample were 
averages of all measurements taken from immediately before and after the start and 
finish of electrospinning. Collection of the fibres continued until a visible sheet of fabric 
was observed (~5 min for microfibres and 15 to 60 minutes for nanofibres). The final 
scaffolds, still on foil, were then stored in a sealed bag at around 4oC until use.
2.3. Scaffold Preparations
Small sections of aligned fibre scaffolds, 35 x 35 mm, were cut then fixed onto the flat 
underside of 35 mm outer and 25 mm inner diameter 316L stainless steel rings coated 
with 100 ml of 10% w.t. PCL in DCM. After the sections had dried they were moistened 
with 70% IMS. With gentle encouragement the scaffolds were peeled off from their 
metallic supports. They were independently re-stretched and relaxed in 2.5ml 70% 
IMS in 6-well plates then submerged with 316L stainless steel wire frames, fig 2.1, for a 
minimum of 30 minutes. To remove residual IMS the scaffolds were kept in sterile PBS 
overnight under UV light.
Fig 2.1: Schematic of scaffold set-up
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2.4. NSC-34 Murine Motor Neuron Cell Line
NSC-34 cells between passages 12-18 were used for all experiments. Stock NSC-34 was 
passaged at 70-80% confluence, with the conditioned NSC medium (cNM) retained. 
Whilst the cNM was centrifuged at 400 rpm for 4 mins to remove debris NSC-34 were 
blasted off the culture dish with 3ml fresh NSC medium with repeated pipette motion. 
Once all cells were lifted the suspension was diluted with more NSC medium to 28,000 
cells/ml then split into aliquots of 1ml onto each scaffold (or well) of a 6-wells plate. Each 
well was supplemented with 1 ml of the supernatant from the centrifuged cNM before 
incubation at 37oC and 5% CO
2
. The remainder of the undiluted NSC-34 suspension was 
then re-plated as stock with fresh NSC medium to generate fresh conditioned media. 
After 24 hours the medium of stock NSC-34 culture was switched to serum-reduced 
NSC34 media (SRNM) to generate fresh conditioned SRNM (cSRNM) for subsequent 
media changes. At 48 hrs the media of the 6-wells were switched to 2ml of 1:1 v:v ratio 
of the SRNM and cSRNM to encourage neurite growth. From henceforth the medium 
was continually changed three times a week for 14 days before the samples were 
immunolabelled for confocal imaging. 
2.5. Primary In Vitro MND Models
2.5.1. Scaffold Preparations for Primary Cultures 
After an overnight incubation in PBS, the scaffolds and control wells (all classed as 
scaffolds from henceforth) were submerged 1.5 ml pORN at 4oC overnight. The solution 
was then switched to 1 ml laminin and the scaffolds were incubated at 37oC, 5% CO
2
 
for 2-3 hours. Just before plating the laminin solution was replaced with 1 ml of PMN 
supplemented media (PSM).
2.5.2. E13 Murine Spinal Cord Dissociates
Pregnant CD-1 mice at E13.5 gestation were sacraficed by cervical dislocation in 
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accordance with the Animals (Scientific Procedures) Act 1986 relating to Schedule 1 
procedures. The embryos were extracted then submerged in HBSS+. The embryos were 
then decapitated and the tails removed. Incisions were made along the two edges of the 
spinal column to isolate the spinal cord. After the removal of the meninges, up to two 
spinal cords were temporarily stored in ice cold 180 ml aliquots of HBSS+. After all spinal 
cords were isolated, 20 ml of TrypA were incubated with each aliquot for 15 mins at 37oC, 
5% CO2. Trypsination was stopped by the addition of 20 ml of trypI. After gentle mashing 
the spinal cord tissues were homogenised by repeated pipette motion to a maximum of 
15 times. The suspension was then diluted into PSM to 900,000 cells/ml, 1 ml of which 
were then added to each of the pre-prepared scaffolds and controls. The samples were 
incubated at 37oC, 5% CO
2
 for 6 days, before immunolabelling for confocal microscopy. 
Half of the medium was replaced by fresh PSM every 2-3 days.
2.5.3. E13 Murine Motor Neurons
In separate 12-well plates each well was coated with 1 ml of the anti-p75 (promotor of 
neuron differentiation) for 1-2 hours at room temperature. Following the dissociation of 
E13.5 spinal cords the coating solution in the 12-wells was switched to 1 ml per well PMN 
base media (PBM) which the homogenised aliquots were then seeded into. For 30-40 
minutes at room temperature the motor neurons in the aliquots selectively adhered to 
the coating. After a single wash with PBM, the remaining motor neurons were detached 
using 10ml depolarisation solution then resuspended in an additional 990 ml/well PSM. 
The suspension was then diluted to result in 100,000 cells per 6-well. The samples were 
incubated at 37oC, 5% CO
2
 for 6 days, before immunolabelling for confocal microscopy. 
Half of the media was replaced with fresh PSM every 2-3 days.  
2.6. Immunolabelling
On immunolabelling, culture medium was removed and samples were fixed with formalin 
for 15 minutes. They were permeabilised with 0.5% Triton X-100 for 5 minutes at 4oC 
before being blocked with 2.5 wt% BSA in PBS for one hour. They were then incubated 
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with primary antibodies, table 2.1, for 90 minutes at room temperature. Afterwards, 
the samples were incubated, also at room temperature, with secondary fluorescent 
antibodies, table 2.2, for 2 hours. Five minutes before final washes 10 ml of DAPI was 











 respectively, were incubated in parallel as above to study the ratio of neurons versus 
glia.









 respectively, were incubated in parallel as above to study the ratio of neurons versus 
glia.









) respectively were co-incubated with the samples as above.
2.7. Imaging
2.7.1. Scanning Electron Microscopy
Scanning Electron Microscopy work was conducted at the Sorby Centre, part of the 
Material Science and Engineering Department of the University of Sheffield. Electrospun 
fibre scaffolds were evaluated by using either Jeol JSM6400 SEM or CamScan Mk2 SEM. 
Scaffold samples were mounted onto 15mm aluminium stubs using a graphite-based 
adhesive whilst still on their aluminium support. They were subsequently gold sputtered 
at 15 mA under Argon for 1 min. On imaging, electron micrographs were obtained at an 
accelerating voltage of 12kV and currents of under 30mA. The working distance was set 
at either 18mm (JEOL) or 35mm (CamScan).
2.7.2. Confocal Microscopy
Confocal imaging was performed at the Kroto Research Institute Confocal Imaging Facility 
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using the Zeiss LSM510 Meta upright confocal microscope. Images (1332 x 1332 pixels) 
were obtained using objectives of either W N-Achroplan 10x/0.3, 40x/0.75 or 63x/0.9, 
with a pixel dwell time of 2.46 ms/pixel. Anti-mouse IgG and anti-rat IgG conjugated 
with Texas red (l
ex
 = 595nm, lem = 615nm) were excited with HeNe 543 nm laser at 0.96 
mW with its emission spectrum between 565-615 nm used for imaging. Anti-rabbit IgG 
and anti-rat IgG conjugated with green fluorescein (l
ex
 = 494nm, lem = 521nm) were 
excited with Ar 488 nm laser at 3% transmission. Its emission spectrum between 500-
550 nm was used. The spectral emissions of DAPI between 435-485 nm were imaged 
after excitation via the multiphoton Ti-Sapphire 760 nm laser at 58.04 mW.
2.8. Image Analyses
All images were analysed in the jpeg format using the analytical tools in Adobe 
Photoshop CS5. Angular degrees were measured against image normal and corrected 
for equivalence. They were then normalised using the mean as the point of reference to 
obtain residual values which were used for statistical analyses. Measurements of lengths 
for both sets of data were recorded in pixels then scaled up against the image scale bars 
to obtain metric values. 
2.8.1. Measurements of Scaffold Fibres
Fibre scaffolds were magnified up to 5000x to obtain images containing approximately 
20 fibres each. For each scaffold five or more frames were taken to obtain a minimum 
of 100 fibres for comparison as well as to estimate fibre densities. For each fibre the 
diameter was measured by drawing a line perpendicular to its axis at the middle of the 
most consistent stretch along their captured length. Alignment values were taken from 
the angle of this measured line.
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2.8.2. Evaluation of NSC34
NSC34 were imaged at 10x magnification for neuron-neurite analyses.  Neuronal cell 
counts were measured as a means of predicting the impact of scaffolds on cell survival 
and were done by counting the total distinct nuclei per frame. Individual neurites were 
defined as observable processes with distinct hillocks and visibly connected growth 
cones (or axonal termini). The distances along the neurite axes between these sets of 
two points were measured as the neurite length and the total count of such lengths 
was recorded to calculate a ratio to define the degree of neuronal differentiation on 
scaffolds. Alignment values were recorded, as before, as the overall degrees away from 
normal of image of all the lines drawn on top of the defined neurites.   
2.8.3. Evaluation of Primary in vitro Murine Models
Primary models were evaluated at 40x magnification. However, due to difficulties 
in obtaining measurable samples analyses were limited to image comparisons of the 
presence or absence of immunolabelled biomarkers. 2.9. Statistical Analyses
Statistical analyses were conducted using the statistical programming language R. 
Significance for all data sets were defined as having p < 0.05.
Alignment data were first corrected for equivalence before residual values (unit 
distance away from the mean) were calculated to generate histograms with bars defined 
by 2-degree intervals. A normal distribution graph was fitted and overlaid onto the 
histograms to confirm normality. Given the identical means of these data, a Bartlett’s test 
was used to test for the homogeneity of the variances between samples. The greatest 
degree of alignment is defined by the lowest p values as determined against the control 
distributions.
Analysis of variance (ANOVA) was conducted for all other data sets with 
transformation as appropriate for the type of data and distributions observed. For count 
and ratio data, Poisson transformations were employed to calculate the adjusted p 
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significance via TukeyHSD() function. Continuous data of neurite lengths and scaffold 
fibre diameters were assessed visually by plotting the density of the data via the ggplot() 
function and compared with fitted distributions to identify suitable transformations for 
ANOVA.
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Previous studies in nerve regeneration reported the use of 1 mm diameter fibres to be 
the best at guiding in vitro neurite growth following injury of rat dorsal root ganglia14. 
However, 1 mm fibre scaffolds were also at the lower limit within the range of fibre 
diameters used in that study. In the development of in vitro human motor neuron disease 
(MND) models, a motor neuron-like neuroblastoma hybrid cell line (NSC-34) was used 
initially to assess the full range of micro- to nanofibre scaffolds.  This was to identify the 
most suitable scaffold/s that would provide the best environment for cell-cell interactions 
as well as neuronal survival. Once selected, primary murine spinal cord dissociates and 
pure motor neuron cultures were cultured on such scaffolds for morphological analyses. 
To minimise the effects of seeding density, only scaffolds with a minimum of 30% fibre 
occupancy were used.
3.1. Evaluation of aligned PCL fibre scaffolds using NSC-34 cells
Five aligned fibre scaffolds spanning the range of nano- to microfibers were assessed in 
vitro in the control of NSC34 neurite development. The scaffolds used were classified as 
follows: 300 nm (mean= 307 ±13 (SEM) nm); 700 nm (640 ±39nm); 800 nm (669 ±57nm); 
2 mm (2.63 ±145nm) and 4 mm (4150 ±332nm), shown in fig 3.1. On visual inspection, 
although all scaffolds appeared to support NSC34 survival and neurite growth, cells 
cultured on 300 nm and 2 mm appeared to be unhealthy as they displayed a condensed 
morphology.
Assessment of scaffolds’ ability to support neurite growth was measured by 
neurite length after 14 days, fig 3.2A.  The distribution of measured neurite lengths 
exhibited log-normal characteristics; as such, quoted values are the median and the 95% 
confidence intervals (C.I., or the range of neurite lengths that 95% of neurites measured 
would fall into) as well as the total neurites assessed. In descending values the recorded 
values of neurite lengths are as follows: 2mm (118.81mm, 95% C.I. = 16.66-626.67mm, n 
= 27); 700 nm scaffolds (80.66mm, 95% C.I. = 49.71-129.14mm, n = 324); TCP (78.97mm, 
95% C.I. = 41.86-133.75mm, n = 214); 300 nm (71.50mm, 95% C.I. = 24.69-211.61mm, n = 
3. Results
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Fig 3.1: 14 days 10x Confocal images of NSC34 on a range of polycaprolactone fibre scaffolds. 
All samples were stained for b-tubulin III (red) and with DAPI (blue) then imaged. These images 
highlights the improvements in neurite alignments with the use of the aligned fibre scaffolds as 
opposed to the use of traditional flat culture surfaces. Scaffold fibre diameters: cont: Tissue culture 
plastics; A: 307nm, 95% C.I. = 295-319nm; B: 640nm, 95% C.I. = 606-676nm; C: 669nm, 95% C.I. = 
678-735nm; D: 2.63mm, 95% C.I. = 2.40-2.88mm; and E: 4.15 mm, 95% C.I. = 3.83-4.50mm; n = 3
cont A B
C D E
61); 800 nm (59.72mm, 95% C.I. = 26.98-151.88mm, n = 89); and 4 mm (45.35mm, 95% C.I. 
= 20.89-100.59mm, n = 91).  Although significance was observed in ANOVA (p < 0.001), 
no specific scaffold stood out as best.
The ability of scaffolds to control neurite growth was evaluated by the quantity 
known as the relative alignments, fig 3.2B (or fig 3.3 for distribution overlays). The 
measured values for each scaffold were corrected for equivalence for each image and 
evaluated in terms of the residual degrees against the mean. In general, the use of the 
aligned fibre scaffolds significantly improved the alignment of neurite growth (Bartlett 
test for homogeneity: p < 0.0001) with 300 nm appearing to be the best (shown in red 
in fig 3.2B). 
Scaffold presence on NSC34 survival and maturation was assessed by the 
average cell and neurite count per 1 mm2 frame, respectively (fig 3.2C and D). In terms 
of cell counts, NSC34 cells cultured on 700 nm (521 ±334 cells/mm2) appeared to be 
thriving. When analysed via ANOVA, significance was observed against 800 nm (104 
±96 cells/mm2, padj < 0.05), 2 mm (192 ±111 cells/mm
2, padj < 0.05) and 4 mm (187 ±153 
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Fig 3.2: Data on the average cell and neurite counts per 1 x 1 mm frames, neuron-neurite ratio and neurite length and alignments 
were collected for each of the scaffolds.  A: mean and maximum neurite lengths in mm (ANOVA: p <0.001). B: fitted normal 
distributions of the residues of relative alignment of neurites growth calculated from mean degree deviation from normal of image 
(Bartlett’s: p <0.001). C: average cell (ANOVA: p <0.001) and neurite (ANOVA: p <0.001) counts per frame. D: neuron-neurite ratios 































































































cells/mm2, padj <0.05). No significance was observed in the mean cell counts between 
the control (234 ±183 cells/mm2), 300 nm (413 ±223 cells/mm2) and 700 nm scaffolds, 
although significance was observed between 800 nm and 4 mm scaffolds (padj <0.01). 
In terms of neurite counts, significance was observed between TCP (43 ±16 neurites/
mm2) against all cultured on scaffolds: 300 nm (10 ±6 neurites/mm2, padj<0.001); 700 nm 
(23 ±16 neurites/mm2, padj<0.05); 800 nm (13 ±7 neurites/mm
2, padj<0.001); 2 mm (3 ±2 
neurites/mm2, padj <0.001) and 4 mm (6 ±5 neurites/mm
2, padj <0.001). Significance was 
also observed for 2 mm (padj <0.001) and 4 mm (padj <0.01) against 700 nm. However, the 
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N-number (N=3) is low, so caution must be used when drawing conclusions from the 
statistical analysis.
As neurite count is highly dependent on neuronal cell count neuron-neurite 
ratios were also evaluated, fig 3.2D. In terms of average values NSC-34 grown on 800 
nm (0.254 ±0.307) fibre scaffolds were the closest to those grown on TCP (0.269 ±0.147, 
padj = 1.00), which would have suggested it to be optimal. However, on closer evaluation 
when scaffolds were further classified according to the age of the plated NSC34 the 
neuron-neurite ratio were statistically identical: P14, 700 nm (0.064 ±0.048) v 4 mm 
(0.062 ±0.064), padj = 1.00; P16, TCP v 800 nm, as mentioned earlier; and P22, 300 nm 
(0.026 ±0.010) v 2 mm (0.029 ±0.064), padj = 1.00. These results gave rise to uncertainty 
as to whether the observed differences in cell/neurite counts were due to the scaffold 
fibre diameters themselves or due to the age of the NSC34 cells. 
From this set of experiments, evidence emerged pointing towards the use of 
submicron fibres, including the most dramatic improvement in neurite alignment and 
the higher cell density observed. However, the mild significance between micro- and 
nanofibres as well as the uncertainty generated from the separation of NSC34 cultures 
by age suggested the need for further evaluation.
Fig 3.3: Relative Alignments of Preliminary NSC34 Neurites on Selected Scaffolds.
Histograms of residual values of transformed neurite alignment data classified by 2o intervals. Red curve is the fitted 
normal distribution plot.
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3.2. Extended NSC34 Models
Following the uncertainty observed in the preliminary experiments the range of scaffolds 
used was reduced to submicron fibre diameters and assessed in parallel for each set 
of comparative experiments. The scaffolds used were fine (mean = 201 ±9 (SEM) nm), 
medium (405 ±19nm) and thick (mean = 598 ±38nm) as well as tissue culture plastics as 
control. In addition, passages 13, 14, 16 and 17 of NSC34 cells were evaluated.
In general the effects of submicron fibre scaffolds on the survival and 
differentiation of NSC34 cells appeared to be limited to restricting the total cell count 
to approximately one third of those cultured on control (fig 3.4A; TCP: 614 ±158/mm2; 
fine: 152 ±81/mm2; medium: 141 ±98/mm2; thick: 119 ±84/mm2). No significance was 
observed between scaffolds. When passage number was taken into account a general 













































































Fig 3.4: Data on the average cell and neurite counts per 1 x 1 mm frames, neuron-neurite ratio and neurite length and 
alignments were collected for each of the scaffolds.  A: average cell (ANOVA: p <0.001) and neurite (ANOVA: p <0.001) 
counts per frame. B: neuron-neurite ratios (ANOVA: p <0.001). Significance denoted by * p < 0.05, ** p < 0.01, *** 
p < 0.001, n = 3 C: mean and maximum neurite lengths in mm (ANOVA: p <0.001). D: fitted normal distributions of 
the residues of relative alignment of neurites growth calculated from mean degree deviation from normal of image 




Candy Ho MPhil 2014
56 57
Fig 3.5: Effect of Passage on Cell Survival. Simple line chart demonstrating the effect of passage number on the total cell/

































































































Fig 3.6: Effect of Passage on NSC34 Neuron-Neurite Ratio. Neuron-neurite ratio of extended NSC34 experiments as 
separated by scaffolds. Labels are as follows: TCP (control); fine (mean = 201 nm, 95% C.I. = 153-265 nm); medium (405 
nm, 95% C.I. = 348-472 nm); and thick (598 nm, 95% C.I. = 552-648 nm)
observed, although the differences were not significant. 
Neuron-neurite ratios were evaluated as before. A slight increase was observed 
at higher passages (fig 3.6A and 3.6B) for both the control and fine fibre scaffolds, 
although a minor decrease was observed for medium scaffolds and almost no change in 
thick fibre scaffolds (fig 3.6C and 3.6D). However, statistical analyses proved inconclusive.
Visually, mean neurite lengths were found to be almost identical between all 
scaffolds (TCP: median = 72.36 mm, 95% C.I. = 56.08-88.62 mm, n = 1329; fine: 65.07 mm, 
95% C.I. = 49.39-83.78 mm, n = 954; medium: 62.75 mm, 95% C.I. = 49.84-90.54 mm, n = 
617; and thick: 58.30 mm, 95% C.I. = 40.95-83.18 mm, n = 506; fig 3.4C, raw distributions 
shown in fig 3.7). However, one-way and two-way log-normal ANOVA against both 
scaffolds and passage showed significance (p<0.001 for all). When adjusted p values 
for all samples were compared significance was mostly observed against p14 samples, 
appendix A.
In the evaluation of relative alignment data, apart from the improvement 
observed via the use of scaffolds, no significance was observed between the use of any 
of the submicron fibre scaffolds (fig 3.4D, histograms and fitted distributions shown in 
fig 3.8). 
Overall, the data suggest the use of p14 NSC34 cultures to be ideal, although 
no statistically significant effects across all types of data were observed to facilitate the 
selection of any particular submicron fibre scaffolds. 
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Fig 3.7: Fitted Distribution of Neurite Lengths. Raw distribution of neurite lengths as plotted via the ggplot() in R. 
Transformation analyses pointed towards a log-normal distribution, p > 0.5.3.3. Primary Murine E13 Spinal Cord Dissociates
Following from the results of the NSC34 studies, the extended models were translated 
for use with primary dissociated murine spinal cord cultures. Early studies suggested 
clustering of dissociated spinal cord cells on microfibre scaffolds with improved cell-
cell scattering/migration on submicron fibre scaffolds (fig 3.9D v fig 3.9B and 3.9C 
respectively). However, differentiation and survival of dissociated spinal cord cultures 
appeared to be hindered when compared with those cultured on tissue culture plastics 
as control (fig 3.9A). 
To improve differentiation and survival of motor neurons in in vitro models, 
poly-l-lysine219 and laminin192, both commonly used in neuronal models, were coated 
on tissue culture plastics and compared against control. Overall, both coatings improved 
cell adhesion. However, poly-l-lysine appeared to induce necrosis (demonstrated by 
the fluorescent rings in fig 3.10C) as well as clustering of glia and neuronal somata (fig 
Fig. 3.8: Alignment Distribution of Extended NSC34 Models. Histogram of relative residual values following transformations 
of relative alignment data of NSC34 neurites culture on submicron fibre scaffolds. All data are classified by 2o separations 
with fitted histogram shown in red.
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3.10D) for dissociated spinal cord cultures. Laminin, on the other hand, significantly 
improved pure motor neuron survival and differentiation (fig 3.10B) as well as supporting 
the dispersion of spinal cord cultures (fig 3.10E) thus allowing greater clarity to study 
individual cells.
The above experiment was repeated on both uncoated and laminin-coated 
nanofibre (405 ±19nm) scaffolds. The resulting spinal cord dissociates exhibited strong 
preference for laminin-coated scaffolds as defined by the much stronger fluorescence 
intensities observed for both S100b and b-Tubulin III immunolabels, used as glial and 
neuronal markers respectively (fig 3.11). However, the survival/differentiation of pure 
motor neuron cultures was not observed. As such all further experiments focused on 
spinal cord dissociates.
Following from the selection of laminin coating, subsequent experiments 
concentrated on the selection of ideal submicron fibres, as used previously for NSC34 
models. Again, no preference was observed for any of the scaffolds. However, the amount 
of cell clustering, as observed previously, was markedly reduced when microfibres were 
used. 
An attempt was made at identifying the degree of differentiation for astrocytes, 
oligodendrocytes and motor neurons which are the target cell types in the development 
of an in vitro human MND model, fig 3.12.  Although S100b labelling suggested presence 
of glial cell types, fluorescence intensities immunolabelled for biomarkers of both 
astrocytes (ALDH1L1 and GFAP) and oligodendrocytes (MBP) were very weak. So much 
so, that such signals were completely eliminated when compared against fluorescence 
intensities of scaffolds cultured with conditioned medium derived from spinal cord 
dissociate cultures. Having considered the time-lag between the differentiation of motor 
DCBA
Fig. 3.9: Primary E10 Murine Spinal Cord Dissociates. Preliminary cultures of primary spinal cord dissociates cultured under 
minimum conditions for 7 days. No coatings or growth factors were used. Scaffolds used were tissue culture plastics (A), 
346 ± 206 nm (B), 735 ± 392nm (C) and 4.75 ± 4.51mm (D) fibre diameter scaffolds. Scale bars represent 100 mm. From 
the images it could be observed that the use of fibres allowed controlled migration of neuroblasts although the degree 
of differentiations were much restricted on the fibres. When the different scaffolds were compared, cells cultured on 
microfibres tended to form strong clusters as opposed to the more dispersed growth of cells cultured on submicron fibres.




Fig 3.10: Confocal images of primary murine E13 motor neuron cultures (seeding density 50,000 cell/ml) and 
spinal cord dissociates (450,000 cells/ml) on coated tissue culture plastics (TCP). Red fluorescence is labeled 
for b-Tubulin III as a generic marker for neurons. Green fluorescence is labeled for S100b as a generic glial 
markers. Unless otherwise stated all images were at 10x magnification and the scale bars represent 100 
mm. Although the use of coatings improved cell adhesion when compared to control (A, no coating) it could 
be observed that the use of laminin was better at supporting motor neuron survival and differentiation 
(B) as the use of poly-L-lysine appeared to stimulate necrosis; demonstrated by the fluorescent ‘rings’ (C). 
In addition, the use of laminin enabled a more dispersed primary mixed glia-neuron culture (spinal cord 
dissociate, shown in D) as compared to strong glial and neural somata clustering seen in E when cultured 
on poly-L-lysine. Image F shows primary E13 spinal cord dissociates cultured on laminin-coated TCP at 40x 
magnification, scalebar represents 20 mm, for clarity.  
A B C
Fig. 3.11: Primary E13 Murine Spinal Cord Dissociates Cultured on Polycaprolactone Nanofibre Scaffolds. Primary E13 
Murine spinal cord dissociates were cultured on bare (A), poly-l-lysine- (B) and laminin-coated (C) polycaprolactone 
nanofibres. Although fluorescence was observed for both labels identifying both b-Tubulin III (red) and S100b (green), 
used as neural and glial markers respectively, the fluorescence intensities of markers for cells cultured on laminin-coated 
polycaprolactone fibres were the strongest. Scalebar represents 20 mm.
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neurons vs astrocytes and oligodendrocytes, the cultures were extended from 6 days 
to thirteen days. However, no difference was observed. Identical results were obtained 
whilst trying to identify motor neurons via the use of Islet-1 immunolabelling. 
From this study, it could be concluded that the use of submicron polycaprolactone 
fibres supported the growth, control and survival of motor neurons as well as glia, 
although the use of laminin improved the results when compared against poly-l-lysine or 
bare fibres. The differentiation of glia into astrocytes or oligodendrocytes as well as their 
ratio in cultures on the scaffolds have yet to be determined as identification markers for 
both cell types appeared to be identical to control (or blank) samples. However, primary 
motor neurons have yet to be successfully cultured on submicron fibre scaffolds.
Fig 3.12: Confocal images of primary murine E13 spinal cord dissociates (1,500,000 cells/ml) cultured on laminin-coated tissue 
culture plastics (A-B) and laminin-coated polycaprolactone medium fibre scaffolds (C-D, 405 nm, 95% C.I. = 348-472 nm fibre 
diameters). Spinal cord dissociates were double immunolabelled for b-tubulin III (red) and S100b (green) to identify glia/neuron 
presence (A,C) and also for b-tubulin III (red) and Islet-1 (green) for motor-neurons (B,D).
A B
C D
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4. Fabrication of Aligned 
Submicron Fibre Scaffolds
Given the emerging evidence pointing towards the preference of neurons for submicron 
fibres, there is an increasing need for the efficient generation of nanofibres with a 
highly controlled morphology. Electrospinning is a simple yet versatile process in the 
fabrication of ultrafine fibres of micro- to nanometre dimensions. However, the major 
limitation to its use for the generation of submicron fibre is the multiple contributions 
of each processing parameter towards the generation of consistent electrostatic jets, 
which on collection deposits the ultrafine fibres. Environmental parameters such as 
temperature, relative humidity and atmospheric conductivity are some of the most 
difficult and expensive parameters to control in a practical manner as they require a 
climate-controlled facility. However, by an understanding of the inter-relationships of 
common processing parameters towards the equilibrium between the electrostatic 
and viscoelastic instabilities, which result in electrostatic jets, a control of fibre scaffold 
consistencies would become possible without significant increases in production costs. 
Polycaprolactone (PCL, Mw = 80,000) is a long chain polyester that is naturally 
degraded by hydrolysis or via the tricarboxylic acid cycle. Using between 5-20% in 
ratios of chloroform and dichloromethane PCL solutions were electrospun by variations 
of several processing parameters against the effects of environmental humidity and 
temperature (parameters that were not controlled for). To minimise as much day-to-
day variation as possible, a fume hood at a constant flow rate of 1 m s-1 air was used. 
Parameter combinations that resulted in an electrospray were discarded. 
4.1. Practical Approach
Given the complexity of the electrospinning process, a practical approach was used 
initially to simplify and logically quantify the relationships between processing 
parameters and final fibre diameters. Following the production of aligned fibre scaffolds, 
samples were taken from the densest regions for scanning electron microscopy. Five to 
eight frames of the scaffold samples were taken on imaging for a decent estimate of the 
Candy Ho MPhil 2014
62 63
density of fibres to select for use in cultures. An approximate total of 100 ±50 fibres per 
sample was taken from the images combined. Distribution analyses of fibre diameters 
demonstrated a predominant log-normal character for all sample scaffolds. As such, all 
fibre diameters are quoted as the median and 95% confidence levels (or the range of 
fibre diameters that 95% of measured fibres would fall into) derived and de-transformed 
from their respective log-distributions.
4.1.1. Effects of Relative Humidity
In electrospinning, the phenomenon of winter vs. summer fibre scaffolds is well known, 
which could be attributed to the difference in relative humidity (f). To assess the precise 
effects of relative humidity on fibre morphology two identical sets of electrospinning 
experiments were conducted both in winter and in summer, which corresponded to 
15.42% f and 45.05% f respectively. In general, an increase in humidity favoured the 
production of thicker fibres, with the most dramatic increase in diameter observed for 
those electrospun at 1 ml/hr flow rate (Q); from 307 nm (95% C.I.  = 247-381nm, n=113) 
to 383nm (95% C.I. =  304-481 nm, n=68) at 0.3 ml/hr and 285 nm (95% C.I. = 223-
364nm, n=102) to 962 nm (95% C.I. = 956-969nm, n=115) at 1 ml/hr, fig 4.1A. It was 
also observed that at 15.42% f, fig 4.1B, the variances between the relative alignments 
of ultrafine fibres produced at both flow rates were fairly consistent (F-test: p > 0.05). 
Fig 4.1: Effect of relative humidity on fibre diameter (A) and relative alignments (B and C). Constant parameters are 
as follows: T (temperature) = 21 oC, 25% chloroform in DCM, V (voltage) = 13 kV, v (velocity of rotating drum) = 660 
m/s, [PCL] = 8%, Needle (dimensions) = 0.55 x 40 mm, y (distance from capillary to collector) = 15 cm, 
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However, at 45.05% f, fig 4.1C, the same could not be said (F-test: p < 0.0005). Although 
the increase of relative humidity at 0.3 ml/hr improved relative alignments (F-test: p < 
0.0005) there was an insignificant decrease at 1 ml/hr (F-test: p > 0.05). This suggests 
that the variation of flow rate alone could not be used to minimise the effects of the 
fluctuation of relative humidity. 
4.1.2. Effects of Concentration
The concentration of a polymer in solution affects the overall viscosity which can limit 
the influence of changes in relative humidity. PCL at concentrations of 8 % w.t. and 10 % 
w.t. ([PCL]) were electrospun at 56% f to produce fibres of 323 nm (95% C.I. = 266-323 
nm, n=130) and 367 nm (95% C.I. = 304-442 nm, n=111) respectively (t.test: p <0.05), 
fig 4.2A. Although the relative alignments of nanofibres generated using PCL at 8% w.t. 
solution was found to be less consistent (F-test: p < 0.05) the overall distribution of 
alignment deviations, fig 4.2B, were of an acceptable level. This suggested 8% w.t. [PCL] 
might be a better concentration to produce nanofibres. However, it must be noted that 
the relatively high relative humidity within which these scaffolds were electrospun might 
actually favour the electrospinning of high consistency aligned nanofibre scaffolds from 
low PCL solution concentrations due to the slower rates of solvent evaporation.
BA
Fig 4.2: Effect of PCL concentration on fibre diameter in mm (A) and alignment 
(B). Constant parameters are as follows: T = 19 oC, f (relative humidity) = 56%, 
25% chloroform in DCM, V = 20 kV, v = 660 m/s, Q (flow Rate) = 0.3 ml/hr, y = 
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Fig 4.3: Effect of solvent system on fibre diameters in mm (A) and alignment (B and C). Constant parameters are as 
follows: T = 19.5 oC, f = 15%, V = 13 kV, v = 660 m/s, [PCL] (concentration of PCL) = 8% w.t., needle = 0.55 x 40 mm, y = 
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4.1.3. Effects of Solvent System
A good use of solvent systems in electrospinning can determine the quality and consistency 
of deposited fibres as the Rayleigh limits and polymer relaxation times are affected. At 
15% f Dichloromethane (DCM), a polar solvent with a relatively good permittivity to 
charge, was supplemented with less polar but more electron-dense solvent, chloroform, 
at 0%, 25% and 50% to dissolve 8 % w.t. PCL. The electrospinning of 0% chloroform-
DCM polymer solution generated an electrospray rather than a jet and was subsequently 
removed from further analyses. For the other two solutions they were both electrospun 
at 0.3 ml/hr Q and 1 ml/hr Q, fig 4.3. With the increase in chloroform percentage a 
consistent decrease of approximately 15% was observed in mean electrospun fibre 
diameters. At 0.3 ml/hr flow rate the mean diameters decreased from 307 nm (95% 
C.I.  = 247-381nm, n=113) to 285 nm (95% C.I. = 223-364nm, n=102) and at 1 ml/hr Q 
it decreased from 259 (95% C.I. = 189-354 nm, n=71) to 231 nm (95% C.I. = 173-311 
nm, n=96). However, when the alignment data for both solvent ratios were compared, 
the use of 25% chloroform in DCM produced more consistent fibres between the two 
flow rates (F-test: p = 0.32, fig 4.3B) as opposed to the dramatic changes seen for 50% 
chloroform in DCM (F-test: p < 0.0005, fig 4.3C). This suggests 25% chloroform in DCM is 
a better solvent system for increasing fibre consistency at 15% f.
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4.1.4. Effects of Voltage and Flow Rate
The voltage and flow rates are two complementary factors in electrospinning that both 
affect the volumetric charge density and therefore the generation of electrostatic jets. 
At 44% f the increase in voltage, from 13kV to 20kV, generated a general decrease 
in diameter: 383nm (95% C.I. = 304-481nm, n=68) to 363nm (95% C.I. = 308-429 nm, 
n=147), p = 0.87, at 0.3 ml/hr; 1.013 mm (95% C.I. = 1.010-1.016 mm, n=100) to 756 nm 
(95% C.I. = 715-799 nm, n=98), p < 0.05, at 1 ml/hr; and 962 nm (95% C.I. = 955-969 nm, 
n=115) to 604 nm (95% C.I. = 527-693nm, n=55), p < 0.05, at 2 ml/hr.  
On comparison of flow rates, significance was observed between 1 ml/hr Q and 
2 ml/hr Q samples against 0.3 ml/hr samples for both voltages (ANOVA: p < 0.0005). 
Although 1 ml/hr and 2 ml/hr samples showed a slight decrease in fibre diameter at 
20kV, no overall significance was observed. 
Increasing flow rate at 13kV decreased relative alignments (fig. 4.4B) but a 
significant improvement was observed at 20kV (fig. 4.4C). However, given the distinct 
pattern observed against flow rate, statistical analyses between relative alignments 
against changes in voltage would be uninformative. 
Overall, the effects of flow rate increased fibre diameters although it decreased 
relative fibre alignments when electrospun at 13kV, whilst increasing relative alignments 
Fig 4.4: Effect of voltage and flow rate on fibre diameter in mm (A) and alignment (B and C). Constant parameters are 
as follows: T = 23 oC, f = 44%, 25% chloroform in DCM, v = 660 m/s, [PCL] = 8% w.t., Needle = 0.55 x 40 mm, y = 15 cm. 
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at 20kV. In comparison an increase in voltage generally decreased fibre diameters except 
for samples electrospun at 0.3 ml/hr. However, this indicated that there was no distinct 
correlation to specify the precise relationship between flow rate and voltage.  4.1.5. Effects of the Distance between Capillary and Collector
The distance between the charged capillary and grounded collector (x) influences the 
gradient of the electric field along which the electrostatic jet stretches to form the 
fibres. At 48% f the increase of x from 10 to 15 cm, of otherwise identical experiments, 
decreased the mean fibre diameter from 640 nm (95% C.I. = 587-698 nm, n=101) to 383 
nm (95% C.I. = 304-481 nm, n=68), p < 0.0001, fig 4.5A. The increase in x was also found 
to improve the relative alignments (F-test: p < 0.0001, fig 4.5B). This suggests that a 
greater distance, or a gentler gradient down the electric field, would be more beneficial 
in increasing scaffold consistency.
4.2. Secondary Parameter Approach
Practical experimental studies identified the unfeasibility of employing simple/primary 













































Fig 4.5: Effect of distance 
between capillary and 
collector on fibre diameter 
(A) and alignment (B). 
Constant parameters are as 
follows: T = 22 oC, f = 48%, 
25% chloroform in DCM, V 
= 13 kV, v = 660 m/s, Q = 
0.3 ml/hr, [PCL] = 8% w.t., 
Needle = 0.55 x 40 mm, *** 
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This was due to the complexity and indirect relationships between physical parameters 
and the final fibre morphology and orientations. Theoretical studies of electrospinning 
established the standard model200,204 put forth by the groups of both Reneker and Yarin, 
which formed the basis for further developments and engineering in this field. However, 
the application of such models towards the production of aligned fibre scaffolds for 
biological studies in standard laboratories is limited due to their incapability of predicting 
fibre and fabric morphology, as that can influence cell differentiation and survival. In 
addition, the range of composite secondary parameters used for the standard model 
is almost as numerous and intricate as those used in practical approaches thus further 
limiting their broader adoption.
Another major limitation to the adoption of current theoretical models as 
secondary controls to the electrospinning process is the consideration of the underlying 
physics behind the generation201,220 and properties221,222 of induced Taylor cones, charge 
break-ups under Rayleigh limits223 and the rate of solvent evaporation. Reviews of latent 
theoretical literature220,222,224,225 as well as studies into solution composite interactions209,226 
provided insight into potential reductions towards a simplified, yet practically applicable, 
model of electrospinning. Using data from practical electrospinning experiments and 
knowledge obtained from literature review, a simplification of the electrospinning model 
is attempted via the use of multivariate ANOVA of primary and secondary parameters 
against measured scaffold morphology. 
Previous assessments suggested a log-normal distribution of scaffold fibre 
diameters and were subsequently evaluated as such in multivariate ANOVA (ANOVA 
Polycaprolactone Chloroform Dichloromethane
molecular weight, Mr, mg/mmol 80,000 119.38 84.93
relative permittivity, er 3.235 4.8069 9.08
viscosity, m, mg/(mm.s) 139.5699 (VBN) 1.5262-0.0018T 1.5247-0.0037T
density, r, mg/mm3 1.1450 2.0315-0.0018T 1.325
surface tension, g, mg/s2 51000.0 64139.176-128.4T 65461.63-129.5T
Vapour pressure, Pv, 10
9 mg/(mm.s2)
     ln Pv = A lnT + B/T + C + DT
2
    Antoine’s constant A - -10.07089 -10.08632
    Antoine’s constant B - -6351.140 -6030.610
    Antoine’s constant C - 81.14393 80.87786
    Antoine’s constant D - 9.127608 9.812512
Table 4.1: Values Used in Electrospinning Model Transformations. Constants: Permittivity of free space, 
e
0
: 8.85418782 x 10-15 C/(V.mm); Coulombs Constant, ke: 8.9875517873681764 x 10
12 (mm.V)/C; Relative 
permittivity of water: 80.1;  Relative permittivity of dry air: 1.00058986
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for simplicity from hence forth; N=75). Given that collector spin rate and dimensions 
of focusing ring were kept constant throughout, they were temporarily eliminated 
from analyses. Preliminary ANOVA of primary parameters identified 352 possible 
combinations, with 115 of them showing significance (p<0.05, Appendix B). Reduction of 
parameters will initiate with logical transformation of simple combination in a stepwise 
fashion until the minimum independent parameters are reached. System constants are 
summarised in table 4.1.
4.2.1. Solution Parameters
Chemical compositions contribute towards the electrospinning process in unison. In 
terms of electrospinning there are three main solution parameters that may affect fibre 
morphology: solution viscosity (m), surface tension (g) and electrical permittivity (e). 
Solution viscosity, m, describes a fluid’s resistance to deformation against external 
stresses. For the current study, it is estimated via the Refutas’ equation of viscosity blends 
(eq. 4.1) using values calculated from recorded correlations with absolute temperature.
The surface tensions of pure components were found to be similar and as such 
the overall surface tension was approximated by the mole fractions of each component 





Eq 4.1: Refutas’ equation of 
viscosity blends. a: transformation 
of dynamic (absolute) viscosity 
(m) into kinematic viscosity (n) 
necessary for the calculation of 
viscosity blend number (VBN); r = 
density. b: calculation of VBN for 
pure components (i). c: summation 
of all VBN accounting for their mole 
fractions (x), VBNb. d: to obtain 
overall n. To obtain overall m, the 
composite n was multiplied by the 
overall density. This equation is for 
viscosities measured in cSt.
a
b
Eq 4.2: a: Oster’s rule on overall 
polarisation, pm, of composite 
medium. vi = molar volume 
of pure component i, pi = 
polarisation of pure component 
i. b: Kirkwood’s theory on 
polarsation against permittivity, 
e. The overall permittivity was 
calculated using the reverse of b.
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The electrical permittivity, e, describes the susceptibility of a dielectric medium 
to permit the transmission of charge under an electric field. It is also a good indicator of 
how well a polymer solution can form Taylor cones. The overall permittivity is estimated 
by the application of Oster’s rule on Kirkwood’s theory on the relationship between 
polarisation and permittivity227 (eq. 4.2). 
Following such transformations, ANOVA was conducted for the interactions 
between relative humidity (f), surface tension (g), viscosity (m), electrical permittivity 
of solution (e), needle diameter, needle length, flow rate (Q), voltage (V), and distance 
between needle tip and collector (y). The number of interactions decreased to 182, with 
74 significant combinations of parameters on scaffold fibre diameter observed.
4.2.2. Environmental parameters
Environmental parameters in electrospinning are predominantly the temperature 
and relative humidity. Given that temperature had mostly been factored into solution 
parameters, focus at this stage is on the effects of relative humidity. The relative 
humidity affects fibre morphology in two major ways. The first way is via its effects on 
the permittivity of the humid air during the propulsion of electrostatic jets (calculated 
as before, using values quoted for dry air and water). The other is on the rate of solvent 
evaporation.
The rate of evaporation is commonly predicted using the Langmuir’s equation, 
which is dependent on the air pressure and the vapour pressure of the evaporating 
liquid. Extended Antoine’s equations for the pure solvents were first applied to obtain 
their respective vapour pressures at the measured absolute temperature for each 
sample. These pressures were then proportionally calculated into Raoult’s law to form 
the vapour pressure of the electrospun solution. As the loss of mass is difficult to predict 
in electrospinning, the difference between humid air pressure and polymer vapour 
pressure is taken as an indicator instead. 
Following these transformation ANOVA of the needle diameter, needle length, 
flow rate, y, viscosity, difference between vapour pressure (P
diff
), voltage, surface tension, 
permittivity of humid air and solution permittivity yielded 265 different parameter 
interactions, with 86 of them showing significance. Following this, it was of note that 
Candy Ho MPhil 2014
70 71
the predominant decrease was on the level of complex parameter interactions which 
showed significance.
4.2.3. Electric Displacement field, D
The electric displacement field is defined as the polarization of a medium under a 
potential difference. It is an important factor in electromagnetism and accounts for the 
ease/difficulty for charge to pass through the induced electric field. In simple dielectrics, 
i.e. air, it is estimated from the electric field multiplied by the permittivity of the local 
medium (eq. 4.3). It is calculated from the potential difference in the system, the 
permittivity of the medium, the dimensions of the charge inducers and the distance 
between the charge inducers and point of interest in space – taken to be the transition 
zone at the Taylor cone apex assumed to be equivalent to the radius of the needle bore. 
In the current electrospinning set-up, the overall electric field is generated by both the 
focusing ring (eq. 4.3.a) and the charged solution segment contained within the syringe 
needle (eq. 4.3.b). 
The revised ANOVA model now contained the electric displacement field, the 
flow rate, y, viscosity, surface tension and P
diff
. This conveniently decreased the interacting 






Eq. 4.3: Calculation of electric displacement field, D. a: the electric displacement field of the system. e = permittivity of the humid 
air. b: electric field due to the charged polymer solution held in needle. ke = Coulomb’s constant. a = distance of point to tip of rod, 
taken to be equivalent to the radius of needle bore where the Taylor cone approximately forms . l = length of needle. c: electric 
field due to the charged focusing ring. x = perpendicular distance of point to central plane of focusing ring, measured to be halfway 
along needle plus a. R
1
 = radius of needle. d: total charge induced into the polymer solution within needle. e = permittivity of 
polymer solution. V = applied voltage. e: total charged induced due to the charged ring. e = permittivity of humid air. w = width of 
focusing ring. R
2
 = radius of focusing ring. 
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4.2.4. Surface Charge Density, rq
In a dielectric material, induced charge is predominantly distributed about the surface 
area. In the current system, the only exposed surface of the polymer solution is located 
at the needle tip, where the Taylor cones form as a result of charge build-up under the 
induced electric field. The level of charge build-up could be predicted using the parameter 
surface charge density, r
q
. This was calculated from the equation proposed by Theron et 




, eq 4.4.b) approximated as shown. 
The new set of parameters analysed via ANOVA now became the electric 
displacement field, the surface charge density, flow rate, P
diff
, y and viscosity. Of the 63 
interacting parameters, a slight decrease to 41 significant interactions on fibre diameter 
was observed.
4.2.5. Reynolds number, Re
Apart from surface charge density, solution flow rate was found to have significant 
interactions with viscosity on the diameter of deposited polymer fibres. Due to the 
dynamic, and potentially turbulent, flow of the polymer solution caused by the effects 
of an electric field, the Reynolds number was used for model simplification (eq 4.5). 
The Reynolds number is a dimensionless parameter that factors in the flow rate and 
the kinematic viscosity (n) to account for the fluid’s internal ratio between inertial and 
viscous forces; the solution’s resistance to changes in velocity and friction between 
Eq 4.5: Calculation of the Reynold 
number, Re. Q = volumetric flow rate. d 
= diameter of the needle. n = kinematic 





Eq 4.4: a: surface charge density197. b: 
volumetric charge density. q
1
 = total 
induced charge of polymer solution, 
calculated from eq 4.3.d. A = cross-
sectional area of needle. l = length of 
needle. c: predicted initial electrostatic 
jet diameter191. Q = volumetric flow rate. 
g = solution surface tension.
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constituent particles, respectively.
Multivariate ANOVA of the new reduced list of parameters (electric displacement 
field, surface charge density, Re, P
diff
 and y) identified 31 different combinations, with 25 
of them showing significance.
4.2.6. Parameter Effects on fibre alignment
Following their identification secondary parameters were compared against fibre 
alignments. Three dimensional plots of the individual residual degrees against two of 
the parameters at a time identified the distance between needle tip and collector (y), 
electric displacement field (D), and surface charge density to have the greatest effects, 
fig 4.6A and fig 4.6B. The Reynolds number (Re) also showed slight effects (fig 4.6C) 
although the difference in vapour pressures, P
diff
, did not appear to have an effect (fig 
4.6D).
Fig 4.6: 3D plots of residual degrees (degrees away from mean) versus distance between needle tip and collector 
(y) and electric displacement field (D, A), surface charge density (rho.q, B), Reynolds number (Re, C) or difference 
between air and solvent vapour pressures (P.diff, D). Significant reductions in the distribution of residual degrees was 
observed for increases in y, D and rho.q. Although an effect was observed for the change in Reynolds number it is 
unreliable due to the low sample count of high Reynold numbers. However, evaluation of the effects of P.diff on the 
distribution of residual degrees proved to be inconclusive. 
A B
C D
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Scaffold studies in the development of an in vitro human motor neuron disease (MND) 
model identified the preference of both the motor neuron cell line NSC34 and E13 
primary spinal cord dissociates for submicron fibre scaffolds. As a result, subsequent 
studies were divided into two parts: i) the continued development of the in vitro model 
and ii) the reduction of processing parameters for the controlled production of aligned 
submicron fibre scaffolds.
5.1. Development of MND Model
In vitro MND models were developed in the present study using electrospun aligned 
fibre scaffolds that were originally designed for peripheral nerve regeneration. This was 
primarily to serve two general purposes. Firstly, the use of ultrafine fibres can artificially 
generate gap distances between fibres to >2mm which had been proven to control 
neurite growth142,229.  Secondly, work conducted using ex vivo dorsal root ganglia14 and 
dissociates215 have suggested the use of submicron fibres can stimulate greater elongation 
of axons with ~300nm diameter fibres proven to be the best215. Results from the present 
study using NSC34, a neuroblastoma cell line that resembled early motor neurons139, and 
primary E13 murine spinal cord dissociates agreed with previous studies.
In order to understand the effects of fibre diameter on the development of in 
vitro MND models the process of neuroblast differentiation into mature neurons would 
need to be investigated. Early research identified 5 stages of this process in hippocampal 
neurons that could be loosely translated for all other neuronal cell types230. In brief, 
spherical neuroblast first generates filopodia at the periphery to facilitate attachment 
onto substrates (stage 1). In stage 2, migration of filopodia drives the formation of growth 
cones that subsequently form processes/neurites. As neurites elongate one would 
selectively form the axon (stage 3) whilst all others retract and develop into dendrites 
(stage 4). The final stage in this process would be the formation of synapses ready for 
use in signal transmission.
Topographical features are principal effectors of submicron fibres on neurite 
5. Discussion
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development229. The very small diameters of submicron fibres dramatically reduce the 
available surface area for environmental sensing109 of filopodia. This pre-determines 
the migratory path of the developing growth cones which restricted the degree of 
dynamic assembly and disassembly of filamentous actin (F-actin)22,231,232. Consequently, 
the engorgement of microtubule molecules233 elongates the developing neurite and 
drives the early entry into stage 2 of neuronal development142,234. In addition, stage 3 
of neuron maturation (axon formation) is governed by the competition of the variable 
combinations of topographical and extraneous influences experienced by individual 
neurites235. However, physical limitations imposed by submicron fibres significantly 
favour neurites that grew parallel to the orientation of the fibres into forming axons, thus 
reducing the time required before the appearance of dendrites. Although not explicitly 
discussed by Christopherson et al215 the earlier formation of axons could explain the 
elevated presence of dendrites and oligodendrocytes observed in their study on the 
differentiation of neural stem cell culture on submicron fibre meshes. 
One of the questions raised from the present study was the decrease in cell 
count observed in NSC34 cultures on fibre scaffolds when compared to flat surface 
controls. With a lack of stimulating factors that can induce neuron maturation except 
for universal serum reduction, it is possible to attribute this decline to the use of the 
fibre scaffolds. Neuroblasts are mitotic cells that would enter a state of quiescent when 
sufficient non-mitotic neurons have been generated to establish a neural network236. In 
embryogenesis, the entry into the dormant state typically follows an explosion in neural 
stem cell numbers superseded by apoptosis of excess neuron progenitors. Although 
NSC34 is a transformed cell line, similar patterns of behaviour have been unofficially 
observed with increasing age of samples used in experiments; which led to the decision 
to only use cells between passages 13 to 20. However, given the fact that submicron fibres 
drive early maturation of neurons, and the fact that limited amounts of morphologically 
apoptotic cells were observed in NSC34 cultures, it raises several questions that will 
be of interest for further investigation. Principally, would the decrease in cell count of 
NSC34 cultured on aligned fibre scaffolds be caused by a) an increase of apoptosis typical 
of neural network formation; or b) early entry into quiescence of non-differentiated 
neuroblasts?
The effects of aligned submicron fibre scaffolds were also studied on both 
primary murine motor neurons and spinal cord dissociates (PSD). Primary motor neurons 
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are highly sensitive to their culture conditions which had often restricted their survival in 
vitro to less than 6 days, which was the experimental period used in the present study. 
Following literature review, the lack of motor neuron survival in the current project is 
most likely caused by the use of serum rather than the presence of the scaffolds as 
demonstrated by Gertz et al who have successfully cultured primary motor neurons on 
submicron fibre scaffolds using serum-free media217,237.
Primary spinal cord dissociates (PSD) consists of a mixture of neurons, astrocytes 
and oligodendrocytes that act synergistically to support each other’s survival. As expected, 
aligned submicron fibre scaffolds were most able to increase the immunoreactivity to 
b-Tubulin III, indicative of differentiated neurons. In the development of MND models, 
tentative adhesion and clustering of early PSD models stimulated an investigation into 
the potential use of laminin or poly-l-lysine (PLL) coating on PCL fibres.  When the 
coatings were compared against nude PCL fibres, the laminin coatings provided the best 
response as shown by immunolabelling for neurons and glia, which was followed by 
the use of PLL coating. PLL is a common coating used in in vitro culture of neurons by 
providing an adhesive surface for cells to adhere. Biologically, they are inert and there 
is evidence that simple adhesion is insufficient to support the maturation of primary 
neurons232,235. Comparatively, laminin is a ligand to the transmembrane integrin receptor 
that is involved in cytoskeletal reorganisation and neurite growth41. Although, it is 
capable of supporting axon elongation during stage 3 in neuron maturation142,235,238, once 
the developing neurons had entered into stage 4 they appeared to lose their sensitivity 
to laminin239. However, in regenerating mature neurons it appeared that this response 
can be restored via alternative pathways following modification to laminin240. 
The interaction between motor neurons, astrocytes and oligodendrocytes is 
an emerging factor when considering the pathophysiology of MND. Early models in the 
present study using 1.5 x 106 cells per 6-well identified good associations between neuron 
and glia. Encapsulation of fibres and neurites by glia were observed as expected, as well 
as the occasional morphological features typical of differentiating oligodendrocytes. 
However, the very high cell density of these models affected quantitative analyses that 
led to a reduction in cell counts to 900,000/6-well in subsequent experiments. Although 
model visibility did improve, neuron/neurite densities were still sufficiently high to 
hinder quantitative analyses.  Furthermore, the loss of the glial signals could potentially 
be attributed to the glia-inhibitory nature of the neurobasal media. Alternatively, it may 
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be indicative of the incomplete maturation of astrocytes or due to an insufficient density 
of oligodendrocytes241. In order to better develop in vitro co-culture human MND models, 
it will be necessary to have a baseline study of pure astrocytes, oligodendrocytes and 
motor neurons to better decipher the mystery of the neuron-glial interactions.
5.2. Electrospinning
Increasing evidence is pointing towards the benefits of nanofibres in the differentiation 
of motor neurons216,217. However, the generation of nanofibres are limited by the high 
sensitivity of electrospinning to environmental factors which is difficult to control. 
Building upon the theoretical models established by Thompson et al200, Theron et al228, 
Tan et al242 and many others an alternative approach was devised to identify potential 
simplifications to the control of submicron electrospinning. 
When considering limiting factors in the controlled electrospinning of aligned 
submicron fibres two principal processes are of primary concern: i) formation of Taylor 
cones201; and ii) stretching of electrostatic jets197. These processes are both derived from 
different combinations of primary parameters all contributing towards the dynamic 
equilibrium between electrostatic and viscoelastic instabilities. 
The formation of Taylor cones is caused by peaks in dynamic surface charge 
densities which are sufficiently rich in potential energy to modify surface topography. 
This energy is chiefly generated by the applied voltage (V) on the dielectric polymer 
solution which leads to an accumulation of charge in the enclosed volume of the needle, 
described by the term volumetric charge density (rv)
200. However, rv is dependent on 
the overall electrical permittivity (e) of the polymer solution used226,243,244. In order to 
generate the electrostatic jet, the accumulated potential energy would have to be 
sufficient to break surface tension (g)220,245 yet low enough to not exceed the Rayleigh 
limit which would result in an electrospray223,246. To limit the potential for the formation 
of an electrospray, the viscosity (m)200,207,228,247 is typically manipulated by the use of high 
molecular weight polymer chains. Yet, the viscosity has to be tightly controlled so as 
to limit the size of the generated Taylor cone and the initial jet diameter (d
0
)220 for the 
electrospinning of submicron fibres. Finally, application of liquid flow rate (Q) and the 
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electric displacement field (D) impose directionality on jet migration, thereby initiating 
the stretching of the electrostatic jet. 
After the formation of the electrostatic jet the electric displacement field, 
determined by the electric field and the electrical permittivity of humid air, drives their 
migration towards the grounded collector. As charge and solvent components are lost 
as the jet migrates (the rate of which is determined by the vapour pressure calculated 
from relative humidity) subsequent changes to the interdependent viscosity and surface 
tension248,249 of polymer solutions stimulate the stretching or bending instability of the 
electrostatic jet204,205. It is this process which further decreases the diameter of the 
electrospun fibres.
Unexpectedly, multivariate ANOVA on the data obtained in the present study 
drew attention to the interaction between needle length and diameter, and the electrical 
permittivity of both the polymer solution and of the electrospinning space. On review, 
these parameters were identified to be those required for the calculation of capacitance, 
which when combined with the interacting voltage provided the overall charge of the 
system. In the set-up employed for the current study there were two separate sources 
of charge: i) from the focusing ring acting on the system; and ii) from the syringe needle 
acting on the flowing polymer solution. These two parameters, once matched with their 
equivalent electric field calculations, could be used in the calculation of electric field 
at specific points in the system; taken as the point where Taylor cones are most likely 
to form, located one radius away from the tip of the needle. Once calculated, the two 
electric fields could then be combined and multiplied by the electrical permittivity of the 
system to form the electric displacement field which described the electrostatic drive of 
the induced polymer jet.
From the remaining combinations of parameter interactions, significance was 
observed between flow rate and viscosity. These two factors can each be used to describe 
the inertial and viscous forces respectively. The ratio between the two forces can be 
defined by a parameter known as the dimensionless Reynolds number. This is a useful 
parameter as it predicts the nature of the solution fluid flow. If high Reynolds numbers 
were obtained, it is very likely that the flow of the electrostatic jet is highly turbulent and 
an increase in the variance of measured fibre diameters are likely, or beads may easily 
be formed. 
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Following numerous transformations, the total number of parameters was 
reduced to a total of 5 (electric displacement field, surface charge density, Reynolds 
number, difference between vapour pressures and the distance between needle tip 
and the collector). However, significance was still observed in the interactions between 
parameters following multivariate ANOVA. This suggests that further reductions to 
the number of processing parameters is possible, although that would require further 
research into fluid dynamics and electrostatics. 
5.3. Concluding Remarks
In the present study the use of aligned submicron fibre scaffolds have been confirmed 
to support the differentiation of NSC34 cells. E13 murine spinal cord dissociates cultured 
on fibre scaffolds had exhibited good neuron-glia associations.  However, the lack of 
mature glial markers or individual neuron resolution of a lower culture density suggests 
the need for pure culture studies as well as modifications to co-culture models. On 
another positive note, successes in the generation of fibroblast-iPSC-derived motor 
neurons from ALS patients within the research group further enhanced the possibility of 
alternative human in vitro 3D model for MND. 
The generation of aligned submicron fibre scaffolds is one of the more difficult 
processes in electrospinning due to the high sensitivity of fibre morphology to changes to 
any one of many parameters. Simplification studies via log-normal multivariate ANOVA 
following secondary transformations of physical parameters successfully reduced the 
number of controlling parameters to 5. However, significant interactions were still 
observed between them. This suggests that further reductions are possible, although 
more research into fluid dynamics and electrostatics would be necessary.
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Appendix
A. Inter-depedent Log-Normal ANOVA of Extended NSC-34 Neurite lengths
 Tukey multiple comparisons of means
    95% family-wise confidence level
Fit: aov(formula = log(length) ~ Scaffold * passage)
$Scaffold
               diff   lwr   upr   p adj
fine-cont     -0.09167079   -0.16864737   -0.0146942062   0.0119217
mid-cont      -0.07933750   -0.16770828     0.0090332860   0.0964696
thick-cont    -0.18894276   -0.28370223   -0.0941832835   0.0000019
mid-fine        0.01233329   -0.08138269     0.1060492799   0.9866775
thick-fine    -0.09727197   -0.19703493     0.0024909956   0.0591339
thick-mid     -0.10960526   -0.21840163   -0.0008088934   0.0475208
$passage
             diff           lwr            upr        p adj
p14-p13        0.17932308     0.11127558     0.247370586   0.0000000
p16-p13       0.07648619   -0.02915271     0.182125081   0.2452242
p17-p13     -0.09937084   -0.25140003     0.052658352   0.3343980
p16-p14     -0.10283689   -0.21124540    0.005571607   0.0702662
p17-p14     -0.27869392   -0.43266048   -0.124727358   0.0000202
p17-p16     -0.17585703   -0.34973864   -0.001975414   0.0462540
$`Scaffold:passage`
                        diff            lwr            upr        p adj
fine:p13-cont:p13      -0.1997748190   0.349116731   -0.050432907   0.0005203
mid:p13-cont:p13      -0.2281301479   -0.388334654   -0.067925641   0.0001257
thick:p13-cont:p13    -0.2124440459   -0.411624735   -0.013263357   0.0233207
cont:p14-cont:p13     -0.0169070142   -0.162513008     0.128698979   1.0000000
fine:p14-cont:p13       0.0552965652   -0.095296119     0.205889250   0.9971393
mid:p14-cont:p13        0.2610662004     0.046917951     0.475214450   0.0031251
thick:p14-cont:p13      0.0110065157   -0.206403961     0.228416993   1.0000000
cont:p16-cont:p13       0.0631960836   -0.129444153     0.255836320   0.9992041
fine:p16-cont:p13      -0.5821788483   -1.236194783     0.071837086   0.1482575
mid:p16-cont:p13        0.0923221550   -0.270277905     0.454922215   0.9999654
thick:p16-cont:p13    -0.3174237410   -0.595949974   -0.038897508   0.0093008
cont:p17-cont:p13            NA             NA             NA          NA
fine:p17-cont:p13      -0.2310000460   -0.630537303     0.168537211   0.8352503
mid:p17-cont:p13      -0.2290417185   -0.598883112     0.140799675   0.7500957
thick:p17-cont:p13    -0.3790995675   -0.682350896   -0.075848239   0.0019917
mid:p13-fine:p13       -0.0283553289   -0.198614226     0.141903568   0.9999999
thick:p13-fine:p13     -0.0126692269   -0.220022922     0.194684468   1.0000000
cont:p14-fine:p13       0.1828678048     0.026267315     0.339468295   0.0063924
fine:p14-fine:p13        0.2550713842     0.093823858     0.416318910   0.0000074
mid:p14-fine:p13        0.4608410194     0.239070686     0.682611353   0.0000000
thick:p14-fine:p13      0.2107813347   -0.014140704    0.435703374   0.0957275
cont:p16-fine:p13       0.2629709026    0.061891643    0.464050163   0.0008323
fine:p16-fine:p13      -0.3824040293   -1.038955208    0.274147150   0.8272388
mid:p16-fine:p13        0.2920969740   -0.075056144    0.659250092   0.3129494
thick:p16-fine:p13     -0.1176489220   -0.402077244    0.166779400   0.9899972
cont:p17-fine:p13   NA             NA             NA          NA
fine:p17-fine:p13      -0.0312252270   -0.434899140    0.372448686   1.0000000
mid:p17-fine:p13       -0.0292668995   -0.403573277    0.345039478   1.0000000
thick:p17-fine:p13     -0.1793247485   -0.488005776    0.129356279   0.8300831
thick:p13-mid:p13      0.0156861019   -0.199623053    0.230995256   1.0000000
cont:p14-mid:p13       0.2112231336    0.044231545    0.378214722   0.0016001
fine:p14-mid:p13        0.2834267131    0.112069654    0.454783772   0.0000018
mid:p14-mid:p13        0.4891963482    0.259970351    0.718422346   0.0000000
thick:p14-mid:p13      0.2391366636    0.006860103    0.471413224   0.0359787
cont:p16-mid:p13       0.2913262314    0.082052855    0.500599607   0.0002149
fine:p16-mid:p13       -0.3540487004   -1.013155617    0.305058216   0.9010956
mid:p16-mid:p13        0.3204523029   -0.051251731    0.692156337   0.1885943
thick:p16-mid:p13     -0.0892935931   -0.379572678    0.200985492   0.9996298
cont:p17-mid:p13   NA             NA             NA          NA
fine:p17-mid:p13       -0.0028698981   -0.410687388    0.404947592   1.0000000
mid:p17-mid:p13       -0.0009115706   -0.379682928    0.377859787   1.0000000
thick:p17-mid:p13     -0.1509694196   -0.465049750    0.163110910   0.9593364
cont:p14-thick:p13     0.1955370317   -0.009142360    0.400216424   0.0799024
fine:p14-thick:p13      0.2677406112    0.059484268    0.475996955   0.0011701
mid:p14-thick:p13      0.4735102463    0.215533463    0.731487030   0.0000000
thick:p14-thick:p13    0.2234505616   -0.037240565    0.484141689   0.1964876
cont:p16-thick:p13     0.2756401295    0.035217982    0.516062277   0.0084993
fine:p16-thick:p13     -0.3697348024   -1.039383509    0.299913905   0.8794122
mid:p16-thick:p13      0.3047662010   -0.085325265    0.694857667   0.3446801
thick:p16-thick:p13   -0.1049796950   -0.418459216    0.208499826   0.9989881
cont:p17-thick:p13   NA             NA             NA          NA
fine:p17-thick:p13     -0.0185560000   -0.443200049    0.406088049   1.0000000
mid:p17-thick:p13     -0.0165976725   -0.413429128    0.380233783   1.0000000
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thick:p17-thick:p13   -0.1666555215   -0.502295085     0.168984042   0.9465371
fine:p14-cont:p14       0.0722035795   -0.085590157    0.229997316   0.9737001
mid:p14-cont:p14       0.2779732146    0.058701284    0.497245145   0.0015336
thick:p14-cont:p14     0.0279135299   -0.194545505    0.250372565   1.0000000
cont:p16-cont:p14      0.0801030978   -0.118217268     0.278423463   0.9921393
fine:p16-cont:p14      -0.5652718341   -1.220983317    0.090439649   0.1886613
mid:p16-cont:p14       0.1092291693   -0.256420267    0.474878606   0.9997408
thick:p16-cont:p14    -0.3005167267   -0.583001362   -0.018032092   0.0241036
cont:p17-cont:p14   NA             NA             NA          NA
fine:p17-cont:p14      -0.2140930317   -0.616399789    0.188213725   0.9077335
mid:p17-cont:p14      -0.2121347042   -0.584966252    0.160696843   0.8517521
thick:p17-cont:p14    -0.3621925532   -0.669083536   -0.055301571   0.0053920
mid:p14-fine:p14        0.2057696351   -0.016844898    0.428384169   0.1082966
thick:p14-fine:p14     -0.0442900495   -0.270044503    0.181464404   0.9999989
cont:p16-fine:p14       0.0078995183   -0.194110428    0.209909465   1.0000000
fine:p16-fine:p14      -0.6374754136   -1.294312228    0.019361401   0.0684005
mid:p16-fine:p14        0.0370255898   -0.330638063    0.404689243   1.0000000
thick:p16-fine:p14     -0.3727203062   -0.657807346   -0.087633267   0.0008375
cont:p17-fine:p14   NA             NA             NA          NA
fine:p17-fine:p14      -0.2862966112   -0.690434927    0.117841704   0.5255860
mid:p17-fine:p14       -0.2843382837   -0.659145453    0.090468885   0.3979610
thick:p17-fine:p14     -0.4343961327   -0.743684229   -0.125108037   0.0001747
thick:p14-mid:p14     -0.2500596847   -0.522358031    0.022238662   0.1146243
cont:p16-mid:p14      -0.1978701168   -0.450831250    0.055091016   0.3425306
fine:p16-mid:p14       -0.8432450487   -1.517497165   -0.168992932   0.0019765
mid:p16-mid:p14       -0.1687440453   -0.566686098    0.229198008   0.9872006
thick:p16-mid:p14     -0.5784899414   -0.901686377   -0.255293505   0.0000001
cont:p17-mid:p14   NA             NA             NA          NA
fine:p17-mid:p14       -0.4920662464   -0.923933233   -0.060199260   0.0093328
mid:p17-mid:p14       -0.4901079188   -0.894659189   -0.085556649   0.0034828
thick:p17-mid:p14     -0.6401657678   -0.984898189   -0.295433346   0.0000000
cont:p16-thick:p14     0.0521895679   -0.203539151    0.307918286   0.9999982
fine:p16-thick:p14     -0.5931853640   -1.268480677    0.082109949   0.1643010
mid:p16-thick:p14      0.0813156393   -0.318391404    0.481022683   0.9999983
thick:p16-thick:p14   -0.3284302567   -0.653797402   -0.003063112   0.0450936
cont:p17-thick:p14   NA             NA             NA          NA
fine:p17-thick:p14     -0.2420065617   -0.675500433    0.191487310   0.8697338
mid:p17-thick:p14     -0.2400482342   -0.646335784    0.166239315   0.8109178
thick:p17-thick:p14   -0.3901060832   -0.736874428   -0.043337738   0.0112618
fine:p16-cont:p16      -0.6453749319   -1.313107442    0.022357578   0.0712914
mid:p16-cont:p16       0.0291260715   -0.357666723    0.415918866   1.0000000
thick:p16-cont:p16    -0.3806198245   -0.689984858   -0.071254791   0.0026588
cont:p17-cont:p16   NA             NA             NA          NA
fine:p17-cont:p16      -0.2941961295   -0.715811929    0.127419670   0.5534458
mid:p17-cont:p16      -0.2922378020   -0.685827078    0.101351474   0.4378373
thick:p17-cont:p16    -0.4422956510   -0.774095637   -0.110495665   0.0005604
mid:p16-fine:p16        0.6745010034   -0.060505968    1.409507974   0.1153267
thick:p16-fine:p16      0.2647551073   -0.432620908    0.962131122   0.9958928
cont:p17-fine:p16   NA             NA             NA          NA
fine:p17-fine:p16        0.3511788023   -0.402735294    1.105092898   0.9691203
mid:p17-fine:p16        0.3531371299   -0.385469057    1.091743317   0.9611665
thick:p17-fine:p16      0.2030792809   -0.504534888    0.910693450   0.9998419
thick:p16-mid:p16     -0.4097458960   -0.845722119    0.026230327   0.0932275
cont:p17-mid:p16   NA             NA             NA          NA
fine:p17-mid:p16       -0.3233222010   -0.844981501    0.198337099   0.7489619
mid:p17-mid:p16       -0.3213638735   -0.820644417    0.177916670   0.6924152
thick:p17-mid:p16     -0.4714217225   -0.923594005   -0.019249440   0.0309685
cont:p17-thick:p16           NA             NA             NA          NA
fine:p17-thick:p16      0.0864236950   -0.380723480    0.553570870   0.9999995
mid:p17-thick:p16      0.0883820225   -0.353635081    0.530399126   0.9999986
thick:p17-thick:p16   -0.0616758265   -0.449693651    0.326341998   0.9999999
fine:p17-cont:p17   NA             NA             NA          NA
mid:p17-cont:p17   NA             NA             NA          NA
thick:p17-cont:p17   NA             NA             NA          NA
mid:p17-fine:p17        0.0019583275   -0.524760077    0.528676732   1.0000000
thick:p17-fine:p17     -0.1480995215   -0.630397137    0.334198094   0.9996376
thick:p17-mid:p17     -0.1500578490   -0.608057440    0.307941742   0.9992158
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B. Preliminary multivariate ANOVA of primary electrospinning parameters against log-transformed fibre diameters
         Df  Sum Sq Mean Sq F value Pr(>F)
temp                                         1 158 157.9 484.226 < 2e-16 ***
humidity                                                                                  1 153 153.3 470.396 < 2e-16  ***
DCM.x.mol         1 260 260.3 798.381 < 2e-16  ***
chloro.x.mol                                                             1 1084 1084.4 3326.397 < 2e-16  ***
needle.bore                                                                               1 50 50.3 154.280 < 2e-16 ***
needle.length                                                                             1 4 4.4 13.388 0.000255 ***
flow.rate                                                                                  1 445 444.9 1364.692 < 2e-16 ***
voltage         1 36 36.2 111.070 < 2e-16 ***
y         1 181 180.9 555.076 < 2e-16  ***
temp:humidity         1 67 66.6 204.280 < 2e-16  ***
temp:DCM.x.mol         1 5 5.0 15.450 8.53E-05 ***
humidity:DCM.x.mol                                                                        1 47 46.7 143.268 < 2e-16  ***
temp:chloro.x.mol        1 27 26.9 82.427 < 2e-16  ***
humidity:chloro.x.mol        1 40 40.3 123.645 < 2e-16  ***
DCM.x.mol:chloro.x.mol        1 106 105.8 324.641 < 2e-16  ***
DCM.x.mol:PCL.x.mol                                                                       1 26 26.2 80.482 < 2e-16  ***
chloro.x.mol:PCL.x.mol         1 45 44.9 137.627 < 2e-16  ***
temp:needle.bore           1 36 36.2 110.962 < 2e-16  ***
humidity:needle.bore            1 0 0.2 0.576 0.447822 
DCM.x.mol:needle.bore                                                                     1 31 31.0 95.181 < 2e-16  ***
chloro.x.mol:needle.bore         1 34 33.9 103.974 < 2e-16 ***
temp:needle.length                                                                        1 1 0.5 1.587 0.20773 
humidity:needle.length        1 5 5.0 15.348 9.00E-05 ***
needle.bore:needle.length                 1 1 0.7 2.190 0.138963 
temp:flow.rate                                                                             1 18 18.4 56.575 5.88E-14 ***
humidity:flow.rate        1 6 5.8 17.939 2.30E-05 ***
DCM.x.mol:flow.rate                                                                        1 0 0.0 0.000 0.991895 
chloro.x.mol:flow.rate         1 0 0.2 0.765 0.381927 
needle.bore:flow.rate        1 4 3.6 11.050 0.00089 ***
temp:voltage         1 1 0.9 2.624 0.105268 
humidity:voltage           1 3 3.0 9.274 0.002331 **
DCM.x.mol:voltage          1 10 9.5 29.253 6.50E-08 ***
chloro.x.mol:voltage            1 3 3.3 10.139 0.001456 ** 
needle.bore:voltage        1 1 1.0 2.935 0.086732 .
flow.rate:voltage          1 1 0.7 2.233 0.135089 
temp:y            1 6 5.6 17.236 3.33E-05 ***
humidity:y         1 6 5.6 17.044 3.68E-05 ***
DCM.x.mol:y                                                                               1 0 0.0 0.050 0.823704 
chloro.x.mol:y          1 27 26.7 81.878 < 2e-16  ***
needle.bore:y                 1 43 43.5 133.333 < 2e-16  ***
flow.rate:y         1 3 3.3 10.013 0.001559 ** 
voltage:y           1 8 7.8 24.058 9.50E-07 ***
temp:humidity:DCM.x.mol        1 7 6.6 20.333 6.58E-06 ***
temp:humidity:chloro.x.mol         1 4 3.6 10.966 0.000931 ***
temp:DCM.x.mol:chloro.x.mol         1 17 17.2 52.902 3.77E-13 ***
humidity:DCM.x.mol:chloro.x.mol       1 4 3.6 11.122 0.000856 ***
temp:DCM.x.mol:PCL.x.mol                                                                 1 0 0.1 0.402 0.525933 
humidity:DCM.x.mol:PCL.x.mol         1 23 22.5 69.103 < 2e-16  ***
temp:chloro.x.mol:PCL.x.mol         1 0 0.2 0.536 0.463964 
humidity:chloro.x.mol:PCL.x.mol       1 3 3.4 10.439 0.001238 **
temp:DCM.x.mol:needle.bore        1 0 0.2 0.531 0.466076 
temp:chloro.x.mol:needle.bore        1 1 0.6 1.904 0.167673 
DCM.x.mol:chloro.x.mol:needle.bore       1 0 0.1 0.247 0.618981 
temp:PCL.x.mol:needle.bore          1 4 3.5 10.738 0.001053 **
chloro.x.mol:PCL.x.mol:needle.bore                                                   1 0 0.0 0.056 0.812511 
temp:DCM.x.mol:needle.length        1 0 0.1 0.367 0.544746 
temp:PCL.x.mol:needle.length       1 0 0.1 0.287 0.592451 
temp:humidity:flow.rate               1 3 3.3 10.118 0.001473 ** 
temp:DCM.x.mol:flow.rate         1 11 11.3 34.777 3.82E-09 ***
humidity:DCM.x.mol:flow.rate         1 1 1.2 3.817 0.050774 .
DCM.x.mol:chloro.x.mol:flow.rate       1 28 28.4 87.064 < 2e-16  ***
temp:PCL.x.mol:flow.rate          1 3 2.8 8.724 0.003147 **
humidity:PCL.x.mol:flow.rate         1 0 0.0 0.043 0.836061 
DCM.x.mol:PCL.x.mol:flow.rate       1 0 0.0 0.005 0.944834 
temp:humidity:voltage       1 2 1.7 5.267 0.02175 * 
temp:DCM.x.mol:voltage       1 3 2.9 8.984 0.002731 **
humidity:DCM.x.mol:voltage         1 39 38.5 118.221 < 2e-16  ***
humidity:PCL.x.mol:voltage          1 3 3.2 9.792 0.001758 ** 
temp:needle.bore:voltage         1 0 0.1 0.306 0.580055 
chloro.x.mol:needle.bore:voltage        1 3 2.7 8.199 0.0042 ** 
PCL.x.mol:needle.bore:voltage       1 2 2.2 6.824 0.009009 **
temp:needle.length:voltage         1 1 1.1 3.326 0.068243 .  
chloro.x.mol:needle.length:voltage       1 0 0.1 0.201 0.653529 
temp:flow.rate:voltage        1 14 14.2 43.712 4.00E-11 ***
humidity:flow.rate:voltage         1 1 1.3 3.934 0.047348 * 
chloro.x.mol:flow.rate:voltage       1 0 0.0 0.027 0.869056 
temp:humidity:y          1 0 0.0 0.042 0.837831 
humidity:DCM.x.mol:y       1 0 0.5 1.413 0.234553 
humidity:chloro.x.mol:y          1 21 20.7 63.364 1.91E-15 ***
DCM.x.mol:chloro.x.mol:y        1 8 7.8 23.826 1.07E-06 ***
humidity:PCL.x.mol:y         1 0 0.1 0.383 0.536249 
chloro.x.mol:PCL.x.mol:y       1 3 3.4 10.381 0.001277 ** 
temp:flow.rate:y           1 5 5.1 15.677 7.57E-05 ***
humidity:flow.rate:y         1 0 0.0 0.107 0.74346 
chloro.x.mol:flow.rate:y          1 1 1.0 2.929 0.087058 .  
temp:voltage:y          1 0 0.0 0.005 0.945375 
DCM.x.mol:voltage:y        1 0 0.1 0.303 0.58232 
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PCL.x.mol:voltage:y         1 1 0.9 2.846 0.091649 .
temp:humidity:DCM.x.mol:needle.bore        1 0 0.4 1.199 0.273604 
temp:humidity:chloro.x.mol:needle.bore        1 0 0.0 0.030 0.861728 
temp:DCM.x.mol:chloro.x.mol:needle.bore      1 1 0.7 2.182 0.139625 
temp:humidity:PCL.x.mol:needle.bore       1 0 0.5 1.448 0.228905 
temp:DCM.x.mol:PCL.x.mol:needle.bore       1 0 0.2 0.581 0.445769 
temp:chloro.x.mol:PCL.x.mol:needle.bore       1 0 0.0 0.114 0.735586 
humidity:chloro.x.mol:PCL.x.mol:needle.bore     1 0 0.3 0.982 0.321732 
humidity:DCM.x.mol:chloro.x.mol:needle.length      1 0 0.3 0.941 0.33204 
humidity:DCM.x.mol:PCL.x.mol:needle.length      1 0 0.0 0.071 0.790343 
temp:chloro.x.mol:PCL.x.mol:needle.length      1 0 0.1 0.441 0.506526 
humidity:chloro.x.mol:PCL.x.mol:needle.length        1 0 0.1 0.170 0.680139 
chloro.x.mol:PCL.x.mol:needle.bore:needle.length           1 1 1.0 3.040 0.081242 .  
temp:humidity:chloro.x.mol:flow.rate        1 0 0.4 1.359 0.243752 
temp:DCM.x.mol:chloro.x.mol:flow.rate      1 3 3.3 10.081 0.001503 **
temp:humidity:PCL.x.mol:flow.rate       1 0 0.3 0.905 0.341573 
temp:chloro.x.mol:PCL.x.mol:flow.rate       1 0 0.1 0.373 0.541426 
DCM.x.mol:chloro.x.mol:PCL.x.mol:flow.rate      1 0 0.2 0.649 0.420561 
DCM.x.mol:chloro.x.mol:needle.bore:flow.rate     1 1 0.7 2.194 0.138598 
temp:PCL.x.mol:needle.bore:flow.rate       1 0 0.0 0.009 0.923682 
DCM.x.mol:PCL.x.mol:needle.bore:flow.rate      1 0 0.1 0.235 0.627566 
temp:DCM.x.mol:needle.length:flow.rate       1 1 0.5 1.575 0.20949 
humidity:DCM.x.mol:needle.length:flow.rate       1 0 0.0 0.110 0.740421 
DCM.x.mol:chloro.x.mol:needle.length:flow.rate     1 2 1.7 5.272 0.021688 * 
temp:PCL.x.mol:needle.length:flow.rate      1 1 0.9 2.641 0.104202 
temp:humidity:DCM.x.mol:voltage       1 0 0.4 1.178 0.277886 
temp:humidity:chloro.x.mol:voltage       1 0 0.1 0.316 0.5739 
humidity:DCM.x.mol:chloro.x.mol:voltage      1 1 0.9 2.784 0.095255 .  
DCM.x.mol:chloro.x.mol:needle.bore:voltage       1 1 0.5 1.655 0.198283 
DCM.x.mol:PCL.x.mol:needle.bore:voltage      1 0 0.0 0.114 0.73516 
chloro.x.mol:PCL.x.mol:needle.bore:voltage       1 0 0.1 0.347 0.55556 
temp:humidity:needle.length:voltage       1 0 0.0 0.120 0.729224 
humidity:DCM.x.mol:needle.length:voltage     1 0 0.0 0.016 0.90077 
temp:chloro.x.mol:needle.length:voltage      1 0 0.0 0.114 0.736178 
DCM.x.mol:chloro.x.mol:needle.length:voltage        1 0 0.1 0.341 0.559208 
temp:PCL.x.mol:needle.length:voltage       1 1 0.9 2.612 0.10611 
DCM.x.mol:PCL.x.mol:needle.length:voltage     1 0 0.0 0.082 0.774691 
temp:humidity:flow.rate:voltage      1 2 2.1 6.348 0.011767 *
temp:DCM.x.mol:flow.rate:voltage       1 0 0.1 0.356 0.550813 
temp:PCL.x.mol:flow.rate:voltage      1 2 2.1 6.367 0.011643 * 
humidity:PCL.x.mol:flow.rate:voltage          1 0 0.0 0.000 0.999514 
DCM.x.mol:PCL.x.mol:flow.rate:voltage      1 0 0.0 0.040 0.841037 
chloro.x.mol:needle.bore:flow.rate:voltage      1 0 0.3 0.853 0.355589 
temp:needle.length:flow.rate:voltage      1 0 0.3 0.834 0.361265 
chloro.x.mol:needle.length:flow.rate:voltage     1 5 4.9 14.946 0.000111 ***
needle.bore:needle.length:flow.rate:voltage      1 0 0.0 0.055 0.814572 
temp:humidity:DCM.x.mol:y        1 4 3.9 11.814 0.00059 ***
humidity:DCM.x.mol:chloro.x.mol:y      1 1 1.1 3.344 0.067482 . 
DCM.x.mol:chloro.x.mol:PCL.x.mol:Scaffold$y      1 2 2.2 6.760 0.009336 ** 
temp:humidity:needle.bore:y        1 3 3.1 9.525 0.002033 **
chloro.x.mol:PCL.x.mol:needle.bore:y         1 0 0.3 0.897 0.343603 
temp:DCM.x.mol:needle.length:y       1 3 3.0 9.262 0.002346 ** 
DCM.x.mol:chloro.x.mol:needle.length:y        1 1 0.6 1.919 0.165985 
temp:humidity:flow.rate:y        1 8 8.2 25.136 5.44E-07 ***
humidity:DCM.x.mol:flow.rate:y         1 0 0.1 0.251 0.616298 
temp:chloro.x.mol:flow.rate:y         1 0 0.4 1.135 0.286684 
temp:needle.bore:flow.rate:y         1 0 0.0 0.047 0.828958 
temp:needle.length:flow.rate:y        1 1 0.7 2.138 0.143716 
DCM.x.mol:needle.length:flow.rate:y       1 2 1.6 4.925 0.026493 * 
needle.bore:needle.length:flow.rate:y       1 0 0.0 0.075 0.783991 
temp:DCM.x.mol:voltage:y       1 1 0.9 2.838 0.092086 .  
temp:PCL.x.mol:voltage:y       1 0 0.1 0.334 0.563564 
chloro.x.mol:PCL.x.mol:voltage:y       1 0 0.4 1.145 0.284705 
temp:needle.length:voltage:y       1 0 0.1 0.235 0.628082 
chloro.x.mol:flow.rate:voltage:y        1 3 2.8 8.626 0.003322 ** 
needle.length:flow.rate:voltage:y        1 0 0.1 0.292 0.588999 
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol      1 0 0.0 0.031 0.860002 
temp:humidity:DCM.x.mol:PCL.x.mol:needle.bore       1 0 0.0 0.095 0.757889 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.length     1 0 0.0 0.053 0.817923 
temp:DCM.x.mol:chloro.x.mol:needle.bore:needle.length    1 1 1.3 3.936 0.047299 *  
temp:chloro.x.mol:PCL.x.mol:needle.bore:needle.length    1 0 0.0 0.017 0.89619 
humidity:chloro.x.mol:PCL.x.mol:needle.bore:needle.length     1 0 0.1 0.331 0.564968 
temp:humidity:DCM.x.mol:chloro.x.mol:flow.rate      1 0 0.4 1.287 0.256714 
temp:humidity:DCM.x.mol:PCL.x.mol:flow.rate       1 3 3.2 9.939 0.001623 ** 
temp:humidity:chloro.x.mol:PCL.x.mol:flow.rate     1 3 2.7 8.369 0.003826 ** 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:flow.rate     1 3 2.5 7.819 0.005179 ** 
humidity:DCM.x.mol:chloro.x.mol:needle.bore:flow.rate    1 0 0.0 0.058 0.809695 
humidity:DCM.x.mol:PCL.x.mol:needle.bore:flow.rate     1 1 0.7 2.064 0.15089 
temp:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate      1 0 0.1 0.257 0.612081 
temp:humidity:DCM.x.mol:needle.length:flow.rate     1 1 0.6 1.856 0.173128 
temp:DCM.x.mol:chloro.x.mol:needle.length:flow.rate    1 0 0.1 0.313 0.576052 
temp:humidity:PCL.x.mol:needle.length:flow.rate     1 1 0.9 2.636 0.104517 
temp:DCM.x.mol:PCL.x.mol:needle.length:flow.rate     1 0 0.0 0.027 0.869471 
temp:chloro.x.mol:PCL.x.mol:needle.length:flow.rate      1 0 0.3 1.056 0.304098 
humidity:DCM.x.mol:needle.bore:needle.length:flow.rate     1 2 2.4 7.211 0.00726 ** 
temp:chloro.x.mol:needle.bore:needle.length:flow.rate    1 3 2.8 8.488 0.003582 ** 
DCM.x.mol:chloro.x.mol:needle.bore:needle.length:flow.rate    1 2 2.1 6.527 0.010639 *
temp:PCL.x.mol:needle.bore:needle.length:flow.rate            1 1 0.9 2.903 0.088424 .
DCM.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate     1 0 0.0 0.020 0.886909 
temp:humidity:chloro.x.mol:PCL.x.mol:voltage        1 1 1.1 3.499 0.061422 . 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:voltage      1 6 5.5 16.892 3.99E-05 ***
temp:humidity:DCM.x.mol:needle.bore:voltage      1 1 0.7 2.070 0.150207 
temp:humidity:chloro.x.mol:needle.bore:voltage      1 0 0.3 0.956 0.328114 
temp:DCM.x.mol:chloro.x.mol:needle.bore:voltage     1 0 0.2 0.656 0.417922 
temp:DCM.x.mol:PCL.x.mol:needle.bore:voltage      1 1 1.2 3.794 0.051465 . 
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temp:humidity:chloro.x.mol:needle.length:voltage     1 2 1.9 5.831 0.015767 *
temp:DCM.x.mol:PCL.x.mol:needle.length:voltage        1 0 0.0 0.021 0.885352 
humidity:DCM.x.mol:PCL.x.mol:needle.length:voltage      1 1 0.5 1.613 0.204086 
temp:chloro.x.mol:PCL.x.mol:needle.length:voltage       1 0 0.3 0.815 0.366783 
humidity:chloro.x.mol:PCL.x.mol:needle.length:voltage      1 0 0.1 0.320 0.571753 
temp:humidity:needle.bore:needle.length:voltage      1 0 0.1 0.155 0.693507 
DCM.x.mol:chloro.x.mol:needle.bore:needle.length:voltage    1 0 0.0 0.016 0.900171 
temp:humidity:DCM.x.mol:flow.rate:voltage      1 0 0.2 0.655 0.418199 
humidity:DCM.x.mol:chloro.x.mol:flow.rate:voltage      1 0 0.1 0.174 0.676245 
humidity:chloro.x.mol:PCL.x.mol:flow.rate:voltage      1 0 0.1 0.174 0.676443 
DCM.x.mol:chloro.x.mol:PCL.x.mol:flow.rate:voltage       1 0 0.5 1.509 0.219394 
humidity:DCM.x.mol:needle.bore:flow.rate:voltage      1 0 0.0 0.055 0.814043 
temp:chloro.x.mol:needle.bore:flow.rate:voltage      1 0 0.0 0.073 0.786319 
temp:DCM.x.mol:needle.length:flow.rate:voltage      1 0 0.1 0.253 0.614998 
temp:chloro.x.mol:needle.length:flow.rate:voltage     1 0 0.4 1.284 0.257169 
DCM.x.mol:chloro.x.mol:needle.length:flow.rate:voltage     1 0 0.0 0.109 0.740951 
humidity:PCL.x.mol:needle.length:flow.rate:voltage     1 0 0.4 1.303 0.253748 
DCM.x.mol:PCL.x.mol:needle.length:flow.rate:voltage      1 2 2.0 6.018 0.014179 *  
DCM.x.mol:needle.bore:needle.length:flow.rate:voltage     1 1 0.6 1.773 0.183085 
PCL.x.mol:needle.bore:needle.length:flow.rate:voltage      1 0 0.1 0.396 0.529178 
temp:humidity:PCL.x.mol:needle.bore:y       1 0 0.1 0.296 0.586602 
temp:chloro.x.mol:PCL.x.mol:needle.bore:y       1 0 0.1 0.458 0.498805 
DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:y      1 0 0.0 0.016 0.898341 
temp:humidity:DCM.x.mol:needle.length:y      1 4 3.5 10.879 0.000976 ***
temp:DCM.x.mol:chloro.x.mol:needle.length:y       1 1 1.4 4.311 0.037884 *  
humidity:chloro.x.mol:PCL.x.mol:needle.length:y       1 1 0.5 1.600 0.205956 
temp:DCM.x.mol:needle.bore:needle.length:y      1 1 0.5 1.599 0.206087 
DCM.x.mol:chloro.x.mol:needle.bore:needle.length:y      1 1 1.1 3.476 0.06228 .  
temp:chloro.x.mol:PCL.x.mol:flow.rate:y       1 1 1.4 4.211 0.040198 *
DCM.x.mol:chloro.x.mol:needle.bore:flow.rate:y       1 1 0.8 2.406 0.120891 
DCM.x.mol:PCL.x.mol:needle.bore:flow.rate:y        1 2 2.3 7.186 0.007359 **
chloro.x.mol:PCL.x.mol:needle.bore:flow.rate:y        1 5 5.2 15.965 6.50E-05 ***
temp:DCM.x.mol:needle.length:flow.rate:y       1 1 1.4 4.364 0.036721 * 
temp:PCL.x.mol:needle.length:flow.rate:y       1 0 0.0 0.141 0.707671 
chloro.x.mol:needle.bore:needle.length:flow.rate:y       1 0 0.2 0.477 0.489629 
temp:humidity:DCM.x.mol:voltage:y       1 2 2.4 7.500 0.00618 **
temp:DCM.x.mol:chloro.x.mol:voltage:y       1 1 1.5 4.478 0.034349 *
temp:humidity:PCL.x.mol:voltage:y       1 0 0.1 0.195 0.658453 
temp:DCM.x.mol:needle.bore:voltage:y        1 2 1.8 5.579 0.018198 *  
temp:chloro.x.mol:needle.bore:voltage:y         1 0 0.0 0.000 0.99227 
DCM.x.mol:chloro.x.mol:needle.bore:voltage:y      1 0 0.0 0.054 0.816719 
chloro.x.mol:PCL.x.mol:needle.bore:voltage:y        1 0 0.0 0.013 0.908312 
humidity:DCM.x.mol:needle.length:voltage:y      1 2 2.1 6.304 0.012062 * 
temp:chloro.x.mol:needle.length:voltage:y       1 0 0.1 0.280 0.596549 
DCM.x.mol:PCL.x.mol:needle.length:voltage:y       1 0 0.3 0.800 0.37126 
temp:needle.bore:needle.length:voltage:y       1 2 1.8 5.559 0.018401 *  
DCM.x.mol:needle.bore:needle.length:voltage:y      1 0 0.2 0.579 0.44655 
chloro.x.mol:needle.bore:needle.length:voltage:y      1 0 0.2 0.760 0.383297 
PCL.x.mol:needle.bore:needle.length:voltage:y     1 0 0.2 0.553 0.457115 
temp:needle.bore:flow.rate:voltage:y      1 2 1.7 5.229 0.022234 *  
chloro.x.mol:needle.bore:flow.rate:voltage:y       1 3 3.2 9.837 0.001716 **
temp:needle.length:flow.rate:voltage:y        1 6 6.3 19.206 1.19E-05 ***
humidity:needle.length:flow.rate:voltage:y       1 0 0.0 0.151 0.69797 
chloro.x.mol:needle.length:flow.rate:voltage:y      1 0 0.2 0.481 0.487783 
needle.bore:needle.length:flow.rate:voltage:y        1 0 0.0 0.038 0.846304 
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore     1 1 0.7 2.044 0.152859 
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.length    1 0 0.2 0.540 0.462601 
temp:humidity:DCM.x.mol:chloro.x.mol:needle.bore:needle.length   1 0 0.4 1.352 0.244995 
temp:humidity:DCM.x.mol:PCL.x.mol:needle.bore:needle.length    1 0 0.2 0.501 0.479057 
humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length   1 0 0.0 0.081 0.775683 
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:flow.rate    1 0 0.0 0.141 0.707521 
temp:humidity:DCM.x.mol:chloro.x.mol:needle.bore:flow.rate     1 1 0.9 2.677 0.101858 
temp:humidity:DCM.x.mol:PCL.x.mol:needle.bore:flow.rate     1 0 0.3 1.000 0.317377 
temp:humidity:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate     1 0 0.4 1.199 0.273503 
temp:humidity:DCM.x.mol:chloro.x.mol:needle.length:flow.rate    1 0 0.0 0.124 0.72485 
temp:humidity:DCM.x.mol:PCL.x.mol:needle.length:flow.rate    1 0 0.0 0.044 0.833567 
temp:humidity:chloro.x.mol:PCL.x.mol:needle.length:flow.rate    1 0 0.4 1.219 0.269672 
temp:humidity:chloro.x.mol:needle.bore:needle.length:flow.rate    1 0 0.1 0.346 0.556502 
temp:DCM.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate    1 1 1.3 4.121 0.042388 * 
temp:humidity:DCM.x.mol:chloro.x.mol:needle.bore:voltage    1 2 2.0 5.993 0.01438 * 
temp:humidity:DCM.x.mol:PCL.x.mol:needle.bore:voltage     1 2 1.7 5.100 0.023948 *
temp:humidity:chloro.x.mol:PCL.x.mol:needle.bore:voltage     1 0 0.2 0.614 0.433191 
humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:voltage   1 1 1.0 2.932 0.086851 .  
temp:humidity:DCM.x.mol:PCL.x.mol:needle.length:voltage    1 0 0.0 0.046 0.830578 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.length:voltage    1 0 0.1 0.432 0.511221 
temp:humidity:chloro.x.mol:needle.bore:needle.length:voltage   1 1 1.0 3.138 0.076509 . 
temp:DCM.x.mol:chloro.x.mol:needle.bore:needle.length:voltage    1 1 0.6 1.692 0.193381 
temp:humidity:PCL.x.mol:needle.bore:needle.length:voltage    1 0 0.3 0.818 0.365741 
temp:DCM.x.mol:PCL.x.mol:needle.bore:needle.length:voltage    1 0 0.0 0.038 0.845788 
temp:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:voltage   1 0 0.0 0.080 0.776792 
humidity:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:voltage   1 0 0.3 0.811 0.367988 
temp:humidity:chloro.x.mol:PCL.x.mol:flow.rate:voltage    1 2 2.1 6.446 0.011137 * 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:flow.rate:voltage    1 0 0.5 1.415 0.234297 
temp:humidity:chloro.x.mol:needle.bore:flow.rate:voltage    1 1 1.2 3.722 0.053714 . 
humidity:DCM.x.mol:chloro.x.mol:needle.bore:flow.rate:voltage   1 2 1.5 4.662 0.030858 *  
temp:humidity:PCL.x.mol:needle.bore:flow.rate:voltage    1 1 0.9 2.810 0.093724 . 
humidity:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate:voltage   1 0 0.1 0.316 0.573935 
DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate:voltage   1 1 1.1 3.331 0.068022 .  
temp:DCM.x.mol:chloro.x.mol:needle.length:flow.rate:voltage     1 3 2.5 7.682 0.005589 **
temp:DCM.x.mol:PCL.x.mol:needle.length:flow.rate:voltage    1 0 0.1 0.434 0.509914 
humidity:chloro.x.mol:PCL.x.mol:needle.length:flow.rate:voltage    1 1 1.0 3.031 0.081697 .  
DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.length:flow.rate:voltage    1 1 1.1 3.371 0.066402 . 
temp:DCM.x.mol:needle.bore:needle.length:flow.rate:voltage    1 0 0.0 0.147 0.701424 
temp:chloro.x.mol:needle.bore:needle.length:flow.rate:voltage   1 0 0.0 0.095 0.758445 
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:y      1 0 0.1 0.318 0.572755 
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temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:y    1 0 0.1 0.242 0.622696 
temp:humidity:DCM.x.mol:chloro.x.mol:needle.length:y    1 1 0.5 1.641 0.200207 
temp:humidity:DCM.x.mol:PCL.x.mol:needle.length:y     1 3 2.5 7.791 0.00526 **
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.length:y     1 1 1.1 3.231 0.072307 . 
humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.length:y    1 0 0.3 0.893 0.344641 
temp:humidity:PCL.x.mol:needle.bore:needle.length:y    1 0 0.0 0.007 0.933407 
temp:DCM.x.mol:PCL.x.mol:needle.bore:needle.length:y    1 1 0.7 2.213 0.136886 
temp:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:y    1 0 0.0 0.010 0.921664 
humidity:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:y    1 7 6.6 20.387 6.40E-06 ***
DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:y   1 0 0.1 0.330 0.565437 
temp:humidity:DCM.x.mol:PCL.x.mol:flow.rate:y      1 0 0.0 0.053 0.817452 
temp:DCM.x.mol:PCL.x.mol:needle.bore:flow.rate:y     1 1 0.8 2.393 0.121948 
temp:humidity:DCM.x.mol:needle.length:flow.rate:y     1 0 0.1 0.446 0.504345 
temp:chloro.x.mol:PCL.x.mol:needle.length:flow.rate:y    1 1 0.5 1.649 0.199059 
humidity:DCM.x.mol:needle.bore:needle.length:flow.rate:y    1 1 1.2 3.544 0.059798 . 
humidity:PCL.x.mol:needle.bore:needle.length:flow.rate:y    1 1 0.5 2.584 0.2082 
DCM.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:y    1 2 2.0 5.988 0.014418 *
chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:y    1 3 2.7 8.153 0.004309 **
temp:humidity:DCM.x.mol:PCL.x.mol:voltage:y     1 1 0.9 2.764 0.096445 .  
temp:humidity:PCL.x.mol:needle.bore:voltage:y     1 1 1.0 2.956 0.085587 .  
humidity:DCM.x.mol:PCL.x.mol:needle.bore:voltage:y    1 0 0.1 0.286 0.592878 
humidity:DCM.x.mol:PCL.x.mol:needle.length:voltage:y    1 0 0.3 0.824 0.364004 
DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.length:voltage:y    1 1 1.2 3.662 0.055705 .
temp:DCM.x.mol:needle.bore:needle.length:voltage:y    1 1 0.5 1.572 0.21001 
chloro.x.mol:PCL.x.mol:needle.bore:needle.length:voltage:y    1 2 1.8 5.577 0.018219 *  
temp:humidity:DCM.x.mol:flow.rate:voltage:y     1 1 0.9 2.700 0.100401 
temp:humidity:PCL.x.mol:flow.rate:voltage:y      1 5 5.3 16.265 5.55E-05 ***
temp:humidity:needle.bore:flow.rate:voltage:y     1 0 0.1 0.389 0.532634 
temp:chloro.x.mol:needle.bore:flow.rate:voltage:y     1 1 0.7 2.085 0.14874 
humidity:DCM.x.mol:needle.length:flow.rate:voltage:y    1 1 0.9 2.737 0.098082 .
temp:chloro.x.mol:needle.length:flow.rate:voltage:y    1 3 3.0 9.263 0.002344 ** 
DCM.x.mol:chloro.x.mol:needle.length:flow.rate:voltage:Scaffold$y   1 0 0.0 0.009 0.924405 
DCM.x.mol:PCL.x.mol:needle.length:flow.rate:voltage:y    1 2 2.3 6.939 0.008446 **
chloro.x.mol:needle.bore:needle.length:flow.rate:voltage:y    1 4 3.6 10.927 0.000951 ***
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length  1 0 0.3 0.802 0.370461 
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate   1 0 0.4 1.123 0.289356 
temp:humidity:DCM.x.mol:chloro.x.mol:needle.bore:needle.length:flow.rate  1 0 0.3 0.835 0.360897 
temp:humidity:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate  1 1 0.8 2.406 0.12087 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate  1 0 0.2 0.644 0.422407 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:voltage  1 3 3.5 10.736 0.001054 ** 
humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:voltage  1 1 0.7 2.073 0.150083 
temp:humidity:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate:voltage   1 1 0.6 1.936 0.164141 
humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate:voltage  1 0 0.0 0.118 0.731716 
temp:humidity:DCM.x.mol:PCL.x.mol:needle.length:flow.rate:voltage   1 4 4.1 12.436 0.000423 ***
temp:humidity:chloro.x.mol:PCL.x.mol:needle.length:flow.rate:voltage   1 1 0.8 2.496 0.114204 
humidity:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:voltage  1 1 0.7 2.203 0.137737 
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:y   1 1 1.2 3.810 0.050973 .
temp:humidity:DCM.x.mol:chloro.x.mol:needle.bore:needle.length:y   1 1 0.6 1.753 0.18558 
temp:humidity:DCM.x.mol:PCL.x.mol:needle.bore:needle.length:y   1 0 0.2 0.603 0.437267 
humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:y   1 0 0.2 0.701 0.402549 
temp:humidity:DCM.x.mol:needle.bore:needle.length:flow.rate:y   1 0 0.2 0.651 0.41964 
temp:DCM.x.mol:chloro.x.mol:needle.bore:needle.length:flow.rate:y   1 0 0.0 0.041 0.838718 
temp:humidity:PCL.x.mol:needle.bore:needle.length:flow.rate:y   1 6 5.5 16.875 4.02E-05 ***
temp:DCM.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:y   1 0 0.0 0.002 0.965381 
temp:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:y    1 7 7.4 22.774 1.85E-06 ***
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:voltage:y    1 0 0.4 1.159 0.281621 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.length:voltage:y   1 1 0.7 2.156 0.142037 
temp:DCM.x.mol:PCL.x.mol:needle.bore:needle.length:voltage:y   1 1 0.8 2.312 0.12839 
humidity:DCM.x.mol:PCL.x.mol:needle.bore:needle.length:voltage:y   1 0 0.0 0.004 0.950048 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:flow.rate:voltage:y     1 1 1.2 3.827 0.050452 .  
humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:flow.rate:voltage:y   1 0 0.2 0.688 0.406998 
temp:DCM.x.mol:chloro.x.mol:needle.bore:flow.rate:voltage:y    1 0 0.0 0.059 0.808142 
temp:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate:voltage:y    1 0 0.1 0.172 0.67864 
temp:humidity:DCM.x.mol:needle.length:flow.rate:voltage:y    1 0 0.2 0.668 0.41368 
temp:humidity:PCL.x.mol:needle.length:flow.rate:voltage:y    1 3 2.7 8.385 0.003792 ** 
DCM.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:voltage:y   1 0 0.3 0.799 0.371439 
temp:humidity:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:voltage 1 0 0.1 0.357 0.549956 
temp:humidity:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:voltage  1 2 1.9 5.861 0.015449 * 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:voltage 1 1 0.6 1.894 0.168783 
temp:DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:flow.rate:voltage:y   1 1 1.3 4.090 0.04316 *
temp:humidity:DCM.x.mol:needle.bore:needle.length:flow.rate:voltage:y   1 2 1.8 5.635 0.017629 * 
temp:humidity:PCL.x.mol:needle.bore:needle.length:flow.rate:voltage:y   1 0 0.1 0.191 0.66201 
temp:DCM.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:voltage:y   1 0 0.3 0.961 0.326899 
temp:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:voltage:y  1 1 1.2 3.551 0.059527 .
DCM.x.mol:chloro.x.mol:PCL.x.mol:needle.bore:needle.length:flow.rate:voltage:y  1 1 0.9 2.748 0.097401 .
Residuals                                                                                 9901 3228 0.3   
---      
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1       
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            Df  Sum Sq  Mean Sq   F value Pr(>F)
Scaffold$D.elect        1 3 2.9 7.661 0.00565 ** 
Scaffold$rho.q        1 1065 1064.6 2855.898 < 2e-16  ***
Scaffold$Re        1 241 241.2 647.047 < 2e-16  ***
Scaffold$y        1 583 583.2 1564.535 < 2e-16  ***
Scaffold$P.diff        1 131 131.4 352.46 < 2e-16  ***
Scaffold$D.elect:Scaffold$rho.q      1 8 7.6 20.276 6.78E-06 ***
Scaffold$D.elect:Scaffold$Re       1 1 0.6 1.605 0.20521 
Scaffold$rho.q:Scaffold$Re       1 11 10.9 29.161 6.81E-08 ***
Scaffold$D.elect:Scaffold$y       1 0 0.1 0.198 0.65659 
Scaffold$rho.q:Scaffold$y       1 126 125.6 337.023 < 2e-16  ***
Scaffold$Re:Scaffold$y       1 21 20.7 55.568 9.76E-14 ***
Scaffold$D.elect:Scaffold$P.diff      1 61 61.5 164.914 < 2e-16  ***
Scaffold$rho.q:Scaffold$P.diff      1 268 268.3 719.657 < 2e-16  ***
Scaffold$Re:Scaffold$P.diff       1 13 12.8 34.45 4.51E-09 ***
Scaffold$y:Scaffold$P.diff       1 15 15.3 41.075 1.53E-10 ***
Scaffold$D.elect:Scaffold$rho.q:Scaffold$Re     1 8 8.5 22.752 1.87E-06 ***
Scaffold$D.elect:Scaffold$rho.q:Scaffold$y     1 31 30.7 82.373 < 2e-16  ***
Scaffold$D.elect:Scaffold$Re:Scaffold$y      1 29 28.6 76.838  < 2e-16  ***
Scaffold$rho.q:Scaffold$Re:Scaffold$y      1 47 46.9 125.801 < 2e-16  ***
Scaffold$D.elect:Scaffold$rho.q:Scaffold$P.diff     1 1 1.3 3.563 0.05912 .
Scaffold$D.elect:Scaffold$Re:Scaffold$P.diff     1 1 0.7 1.848 0.17407 
Scaffold$rho.q:Scaffold$Re:Scaffold$P.diff     1 12 11.9 31.801 1.75E-08 ***
Scaffold$D.elect:Scaffold$y:Scaffold$P.diff     1 25 25.5 68.358 < 2e-16  ***
Scaffold$rho.q:Scaffold$y:Scaffold$P.diff     1 19 19.3 51.691 6.95E-13 ***
Scaffold$Re:Scaffold$y:Scaffold$P.diff      1 19 18.9 50.782 1.10E-12 ***
Scaffold$D.elect:Scaffold$rho.q:Scaffold$Re:Scaffold$y    1 7 6.8 18.345 1.86E-05 ***
Scaffold$D.elect:Scaffold$rho.q:Scaffold$Re:Scaffold$P.diff    1 3 3.4 9.048 0.00264 ** 
Scaffold$D.elect:Scaffold$rho.q:Scaffold$y:Scaffold$P.diff    1 6 5.8 15.461 8.48E-05 ***
Scaffold$D.elect:Scaffold$Re:Scaffold$y:Scaffold$P.diff     1 16 15.9 42.614 6.98E-11 ***
Scaffold$rho.q:Scaffold$Re:Scaffold$y:Scaffold$P.diff    1 0 0.3 0.785 0.37555 
Scaffold$D.elect:Scaffold$rho.q:Scaffold$Re:Scaffold$y:Scaffold$P.diff  1 86 86 230.678 < 2e-16  ***
Residuals 10222 3811 0.4   
---      
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1       
